Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Atrial septal defect, ostium primum type ORPHA:99106	9/101	1.8755319325194526E-6	0.004036144718781862	0	0	9.041334966319656	119.22463259377385	KITLG;PCDH7;COL12A1;COL5A2;PLSCR4;LAMA3;SNAI2;LIFR;AMOTL2
Arnold-Chiari malformation type I ORPHA:268882	8/101	1.6929153191211127E-5	0.005184819750490018	0	0	7.912772585669782	86.93346538481532	RPSAP52;KITLG;CCND1;PLK2;ITGA2;COL12A1;SNAI2;AMOTL2
Autosomal recessive nail dysplasia ORPHA:280654	8/101	1.6929153191211127E-5	0.005184819750490018	0	0	7.912772585669782	86.93346538481532	KITLG;CCND1;PLK2;ITGA2;COL12A1;LAMA3;SNAI2;AMOTL2
Hereditary arterial and articular multiple calcification syndrome ORPHA:289601	8/101	1.6929153191211127E-5	0.005184819750490018	0	0	7.912772585669782	86.93346538481532	ITGA2;COL12A1;PLSCR4;SNAI2;PRSS23;THBS1;TGM2;MT1E
Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504	8/101	1.6929153191211127E-5	0.005184819750490018	0	0	7.912772585669782	86.93346538481532	CCND1;PLK2;ITGA2;COL12A1;LAMA3;AMOTL2;PRSS23;CPA4
Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118	8/101	1.6929153191211127E-5	0.005184819750490018	0	0	7.912772585669782	86.93346538481532	KITLG;COL12A1;COL5A2;PLSCR4;LIFR;AMOTL2;RGL1;PRSS23
SIX2-related frontonasal dysplasia ORPHA:488437	8/101	1.6929153191211127E-5	0.005184819750490018	0	0	7.912772585669782	86.93346538481532	ADAMTS15;KITLG;SIX2;COL12A1;SNAI2;AMOTL2;WNT9A;GLI2
Auriculocondylar syndrome ORPHA:137888	8/103	1.954268736543191E-5	0.005184819750490018	0	0	7.745400885391048	83.9826799841783	KITLG;CCND1;PLK2;ITGA2;COL12A1;AMOTL2;PRSS23;THBS1
Peters anomaly ORPHA:708	8/105	2.248685175134143E-5	0.005184819750490018	0	0	7.584931110897004	81.17833038697565	ADAMTS15;KITLG;SIX2;PCDH7;COL12A1;SNAI2;AMOTL2;GLI2
Atrial septal defect, ostium secundum type ORPHA:99103	8/106	2.409302858034395E-5	0.005184819750490018	0	0	7.507152393667748	79.82796583148706	ADAMTS15;COL5A2;SNAI2;LIFR;AMOTL2;SMAD6;RBM24;GLI2
Familial porencephaly ORPHA:99810	7/100	1.2610208076165806E-4	0.008304513120319134	0	0	6.891472868217054	61.87452965785251	ADAMTS15;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Severe generalized junctional epidermolysis bullosa ORPHA:79404	7/100	1.2610208076165806E-4	0.008304513120319134	0	0	6.891472868217054	61.87452965785251	IL22RA1;EHF;ITGA2;COL12A1;LAMA3;AMOTL2;S100A14
20p12.3 microdeletion syndrome ORPHA:261295	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	KITLG;COL12A1;COL5A2;PLSCR4;P3H2;SNAI2;AMOTL2
Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	EHF;ITGA2;COL12A1;LAMA3;S100A14;PRSS23;THBS1
Chondrosarcoma ORPHA:55880	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	CCND1;PLK2;COL12A1;COL5A2;SNAI2;AMOTL2;THBS1
Familial progressive hyper- and hypopigmentation ORPHA:280628	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	KITLG;CCND1;PLK2;PCDH7;COL12A1;LIFR;AMOTL2
Familial progressive hyperpigmentation ORPHA:79146	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	KITLG;CCND1;PLK2;PCDH7;COL12A1;LIFR;AMOTL2
Greig cephalopolysyndactyly syndrome ORPHA:380	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	PCDH7;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	FAM111B;CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1;SPC25
Isolated hyperchlorhidrosis ORPHA:542657	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	KITLG;CCND1;ITGA2;COL12A1;LAMA3;SNAI2;AMOTL2
Kindler epidermolysis bullosa ORPHA:2908	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	IL22RA1;KITLG;CCND1;ITGA2;LAMA3;AMOTL2;S100A14
Laryngo-onycho-cutaneous syndrome ORPHA:2407	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	EHF;KITLG;ITGA2;COL12A1;LAMA3;AMOTL2;S100A14
Pallister-Hall syndrome ORPHA:672	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	PCDH7;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Polysyndactyly ORPHA:93338	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	PCDH7;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	ADAMTS15;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Sensorineural deafness with dilated cardiomyopathy ORPHA:217622	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	SIX2;PCDH7;COL12A1;SNAI2;LIFR;AMOTL2;GLI2
Tibial hemimelia ORPHA:93322	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	PCDH7;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Ulnar-mammary syndrome ORPHA:3138	7/101	1.3423202566688978E-4	0.008304513120319134	0	0	6.817812963879268	60.78721622984028	KITLG;CCND1;COL12A1;SNAI2;LIFR;AMOTL2;SMAD6
Autosomal recessive infantile hypercalcemia ORPHA:300547	7/102	1.4278205643671374E-4	0.008304513120319134	0	0	6.745703794369645	59.72775097936251	IL22RA1;EHF;ABCC2;CYP24A1;PADI3;KRT13;S100A14
Axenfeld anomaly ORPHA:98978	7/102	1.4278205643671374E-4	0.008304513120319134	0	0	6.745703794369645	59.72775097936251	KITLG;CCND1;SIX2;COL12A1;SNAI2;AMOTL2;GLI2
Axenfeld-Rieger syndrome ORPHA:782	7/102	1.4278205643671374E-4	0.008304513120319134	0	0	6.745703794369645	59.72775097936251	KITLG;CCND1;SIX2;COL12A1;SNAI2;AMOTL2;GLI2
Branchiootic syndrome ORPHA:52429	7/102	1.4278205643671374E-4	0.008304513120319134	0	0	6.745703794369645	59.72775097936251	SIX2;PCDH7;SNAI2;LIFR;AMOTL2;RBM24;GLI2
Congenital short bowel syndrome ORPHA:2301	7/102	1.4278205643671374E-4	0.008304513120319134	0	0	6.745703794369645	59.72775097936251	TPM4;COL12A1;COL5A2;SNAI2;THBS1;GLI2;VGLL3
Myelodysplastic syndrome ORPHA:52688	7/102	1.4278205643671374E-4	0.008304513120319134	0	0	6.745703794369645	59.72775097936251	ITGA2;COL12A1;LAMA3;RHOBTB3;LIFR;AMOTL2;SMAD6
Papillary renal cell carcinoma ORPHA:319298	7/102	1.4278205643671374E-4	0.008304513120319134	0	0	6.745703794369645	59.72775097936251	KITLG;COL12A1;PLSCR4;LAMA3;ME1;SNAI2;AMOTL2
Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289	7/102	1.4278205643671374E-4	0.008304513120319134	0	0	6.745703794369645	59.72775097936251	KITLG;ITGA2;COL12A1;LAMA3;SNAI2;AMOTL2;SMAD6
Rieger anomaly ORPHA:91483	7/102	1.4278205643671374E-4	0.008304513120319134	0	0	6.745703794369645	59.72775097936251	KITLG;CCND1;SIX2;COL12A1;SNAI2;AMOTL2;GLI2
Brachydactyly type A2 ORPHA:93396	7/103	1.517683102385662E-4	0.008374497529061397	0	0	6.6750968992248065	58.69516484392459	KITLG;PCDH7;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2
Unverricht-Lundborg disease ORPHA:308	7/103	1.517683102385662E-4	0.008374497529061397	0	0	6.6750968992248065	58.69516484392459	FZD1;KITLG;CCND1;ME1;TIMP2;SNAI2;AMOTL2
Waardenburg syndrome type 2 ORPHA:895	7/105	1.7111596826805566E-4	0.009206039092821394	0	0	6.538205980066445	56.70696577704008	KITLG;PCDH7;COL12A1;PLSCR4;SNAI2;LIFR;AMOTL2
Hereditary breast cancer ORPHA:227535	7/108	2.0383486333532566E-4	0.010698844534088313	0	0	6.343034768593139	53.90438051500731	CENPE;DEPDC1B;SLC22A18;ESCO2;CLSPN;SHCBP1;SPC25
Early-onset nuclear cataract ORPHA:98991	7/118	3.510780997738709E-4	0.0179885731122231	0	0	5.768657029122146	45.88679302615278	ADAMTS15;KITLG;BFSP1;CCND1;SNAI2;AMOTL2;GLI2
Bruck syndrome ORPHA:2771	6/100	8.751177044059128E-4	0.018006422428388378	0	0	5.81678486997636	40.9568673592404	CCND1;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2
Acute inflammatory demyelinating polyradiculoneuropathy ORPHA:98916	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;COL12A1;PLSCR4;TIMP2;LIFR;AMOTL2
Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;COL12A1;SNCG;LIFR;AMOTL2;RBM24
Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;COL12A1;SNCG;LIFR;AMOTL2;RBM24
Autosomal recessive brachyolmia ORPHA:448242	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;COL12A1;PLSCR4;PRSS23;THBS1;TGM2
Autosomal recessive spastic paraplegia type 66 ORPHA:401815	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;P3H2;SNAI2;AMOTL2;GLI2
Bamforth-Lazarus syndrome ORPHA:1226	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CYP24A1;SIX2;LAMA3;PADI3;KRT13;CPA4
CHST3-related skeletal dysplasia ORPHA:263463	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CCND1;COL12A1;SNAI2;LIFR;AMOTL2;GLI2
COL4A1-related familial vascular leukoencephalopathy ORPHA:36383	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Charcot-Marie-Tooth disease type 1A ORPHA:101081	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;COL12A1;PLSCR4;TIMP2;LIFR;AMOTL2
Charcot-Marie-Tooth disease type 1E ORPHA:90658	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;COL12A1;PLSCR4;TIMP2;LIFR;AMOTL2
Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CENPE;DEPDC1B;OIP5;ESCO2;CLSPN;SHCBP1
Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CCND1;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2
Congenital dyserythropoietic anemia type III ORPHA:98870	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1;E2F7
Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	RPSAP52;TPM4;COL12A1;SNAI2;THBS1;TGM2
Craniosynostosis, Boston type ORPHA:1541	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	ADAMTS15;KITLG;BFSP1;CCND1;ZNF703;AMOTL2
Diaphanospondylodysostosis ORPHA:66637	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;PLSCR4;SNAI2;LIFR;AMOTL2
FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome ORPHA:404451	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Familial drusen ORPHA:75376	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;PLSCR4;SNAI2;LIFR;TGM2
Familial multiple nevi flammei ORPHA:624	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	ARRDC4;TSC22D1;SORT1;NRIP1;TIMP2;RHOU
Familial schizencephaly ORPHA:481986	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Filippi syndrome ORPHA:3255	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1;E2F7
GAPO syndrome ORPHA:2067	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
HANAC syndrome ORPHA:73229	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Hereditary neuropathy with liability to pressure palsies ORPHA:640	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;COL12A1;PLSCR4;TIMP2;LIFR;AMOTL2
Hereditary papillary renal cell carcinoma ORPHA:47044	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;CCND1;ITGA2;COL12A1;LAMA3;AMOTL2
Ischiovertebral syndrome ORPHA:85200	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;PLSCR4;SNAI2;LIFR;AMOTL2
Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1;E2F7
Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1;E2F7
Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;PCDH7;COL12A1;SNAI2;LIFR;AMOTL2
Mandibulofacial dysostosis with alopecia ORPHA:443995	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	PCDH7;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2
Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CENPE;DEPDC1B;OIP5;CLSPN;SHCBP1;E2F7
Myopathic Ehlers-Danlos syndrome ORPHA:536516	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;COL12A1;COL5A2;SNAI2;LIFR;AMOTL2
NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	ADAMTS15;COL12A1;COL5A2;SNAI2;AMOTL2;GLI2
Nance-Horan syndrome ORPHA:627	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;PCDH7;COL12A1;AMOTL2;PBX1;GLI2
Neonatal ichthyosis-sclerosing cholangitis syndrome ORPHA:59303	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	IL22RA1;CCND1;ITGA2;LAMA3;AMOTL2;S100A14
Oculocutaneous albinism type 3 ORPHA:79433	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	GPR37;PCDH7;COL12A1;SNAI2;LIFR;AMOTL2
Odonto-onycho-dermal dysplasia ORPHA:2721	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	GPR15;LPAR5;LAMP3;ZBED2;SKAP1;PSMB9
Osteofibrous dysplasia ORPHA:488265	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;CCND1;ITGA2;COL12A1;LAMA3;AMOTL2
PPARG-related familial partial lipodystrophy ORPHA:79083	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;NCEH1;ITGA2;LAMA3;ME1;TGM2
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CCND1;COL12A1;LAMA3;SNAI2;AMOTL2;SMAD6
Parietal foramina with clavicular hypoplasia ORPHA:251290	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	ADAMTS15;KITLG;BFSP1;CCND1;ZNF703;AMOTL2
Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome ORPHA:401959	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	IL22RA1;EHF;ITGA2;LAMA3;PRR15;S100A14
Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Primary CD59 deficiency ORPHA:169464	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;PLSCR4;SNAI2;AMOTL2;PRSS23;TGM2
RIN2 syndrome ORPHA:217335	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	PLSCR4;TIMP2;RGL1;PRSS23;THBS1;TGM2
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;TSC22D1;PLSCR4;LAMA3;LIFR;PBX1
Retinal arterial tortuosity ORPHA:75326	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Roberts syndrome ORPHA:3103	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1;SPC25
Schopf-Schulz-Passarge syndrome ORPHA:50944	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	GPR15;LPAR5;LAMP3;ZBED2;SKAP1;PSMB9
Sorsby pseudoinflammatory fundus dystrophy ORPHA:59181	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;PLSCR4;SNAI2;LIFR;AMOTL2
Spondyloepimetaphyseal dysplasia, PAPSS2 type ORPHA:93282	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;COL12A1;PLSCR4;PRSS23;THBS1;TGM2
Steel syndrome ORPHA:438117	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Stromme syndrome ORPHA:506307	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1;E2F7
Sturge-Weber syndrome ORPHA:3205	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	ARRDC4;TSC22D1;SORT1;NRIP1;TIMP2;RHOU
Synpolydactyly type 2 ORPHA:295197	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;CCND1;COL12A1;SNAI2;LIFR;AMOTL2
Woolly hair-palmoplantar keratoderma syndrome ORPHA:420686	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	CCND1;COL12A1;COL5A2;SNAI2;AMOTL2;SMAD6
X-linked osteoporosis with fractures ORPHA:391330	6/101	9.219106765563282E-4	0.018006422428388378	0	0	5.755263157894737	40.2238922983475	KITLG;CCND1;COL12A1;SNAI2;LIFR;AMOTL2
Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form ORPHA:79408	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	CCND1;ITGA2;COL12A1;COL5A2;SNAI2;AMOTL2
Congenital cataract microcornea with corneal opacity ORPHA:289499	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	ADAMTS15;GPR37;COL12A1;LIFR;AMOTL2;GLI2
Congenital diaphragmatic hernia ORPHA:2140	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	COL12A1;PLSCR4;RHOBTB3;SNAI2;LIFR;AMOTL2
Dermatofibrosarcoma protuberans ORPHA:31112	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	ADAMTS15;CCND1;COL12A1;COL5A2;PDGFB;AMOTL2
Familial primary localized cutaneous amyloidosis ORPHA:353220	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	ITGA2;COL12A1;SNAI2;PRSS23;THBS1;CPA4
Hypoplastic left heart syndrome ORPHA:2248	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	PCDH7;COL5A2;SNAI2;LIFR;AMOTL2;GLI2
Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	IL22RA1;EHF;ITGA2;LAMA3;AMOTL2;S100A14
Matthew-Wood syndrome ORPHA:2470	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	PCDH7;COL5A2;LIFR;AMOTL2;PBX1;GLI2
NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	CENPE;DEPDC1B;OIP5;ESCO2;CLSPN;SHCBP1
Neonatal inflammatory skin and bowel disease ORPHA:294023	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	KITLG;CCND1;PLK2;ITGA2;COL12A1;AMOTL2
Pediatric hepatocellular carcinoma ORPHA:33402	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	KITLG;CCND1;PLK2;ITGA2;COL12A1;AMOTL2
Piebaldism ORPHA:2884	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	COL12A1;COL5A2;PLSCR4;SNAI2;LIFR;GLI2
Posterior hypospadias ORPHA:95706	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	COL12A1;COL5A2;SNAI2;LIFR;AMOTL2;RBM24
Rolandic epilepsy-speech dyspraxia syndrome ORPHA:163721	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	PCDH7;COL12A1;COL5A2;PLSCR4;LIFR;AMOTL2
Trichorhinophalangeal syndrome type 2 ORPHA:502	6/102	9.706064134261392E-4	0.018006422428388378	0	0	5.695023148148148	39.5097328707226	PLK2;COL12A1;SNAI2;AMOTL2;PRSS23;THBS1
BOR syndrome ORPHA:107	6/103	0.0010212563964764575	0.018314531376811136	0	0	5.6360252004581906	38.813736759092656	CCND1;SIX2;SNAI2;LIFR;AMOTL2;GLI2
Dedifferentiated liposarcoma ORPHA:99970	6/103	0.0010212563964764575	0.018314531376811136	0	0	5.6360252004581906	38.813736759092656	CENPE;DEPDC1B;RPSAP52;CLSPN;SHCBP1;E2F7
Erythrokeratodermia variabilis ORPHA:317	6/103	0.0010212563964764575	0.018314531376811136	0	0	5.6360252004581906	38.813736759092656	ITGA2;COL12A1;LAMA3;SNAI2;AMOTL2;S100A14
Well-differentiated liposarcoma ORPHA:99971	6/103	0.0010212563964764575	0.018314531376811136	0	0	5.6360252004581906	38.813736759092656	CENPE;DEPDC1B;RPSAP52;CLSPN;SHCBP1;E2F7
Ondine syndrome ORPHA:661	6/105	0.0011286278383742523	0.020072786018028022	0	0	5.521604938271605	37.473767148297334	SCHIP1;COL12A1;COL5A2;SNAI2;SCG2;GLI2
Tetralogy of Fallot ORPHA:3303	6/112	0.001573811367524629	0.027761000515680343	0	0	5.155136268343815	33.27256392691913	ADAMTS15;COL5A2;LIFR;AMOTL2;SMAD6;GLI2
Classical Ehlers-Danlos syndrome ORPHA:287	5/100	0.005166297548807455	0.0586579655822394	0	0	4.7739510065486295	25.137711590961093	COL12A1;COL5A2;SNAI2;AMOTL2;GLI2
Hereditary site-specific ovarian cancer syndrome ORPHA:213524	5/100	0.005166297548807455	0.0586579655822394	0	0	4.7739510065486295	25.137711590961093	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1
Intermediate generalized junctional epidermolysis bullosa ORPHA:79402	5/100	0.005166297548807455	0.0586579655822394	0	0	4.7739510065486295	25.137711590961093	IL22RA1;EHF;ITGA2;LAMA3;S100A14
Localized junctional epidermolysis bullosa ORPHA:251393	5/100	0.005166297548807455	0.0586579655822394	0	0	4.7739510065486295	25.137711590961093	IL22RA1;EHF;ITGA2;LAMA3;S100A14
Multiple osteochondromas ORPHA:321	5/100	0.005166297548807455	0.0586579655822394	0	0	4.7739510065486295	25.137711590961093	CCND1;COL12A1;COL5A2;SNAI2;AMOTL2
X-linked Alport syndrome-diffuse leiomyomatosis ORPHA:1018	5/100	0.005166297548807455	0.0586579655822394	0	0	4.7739510065486295	25.137711590961093	KITLG;PCDH7;COL12A1;LIFR;AMOTL2
15q14 microdeletion syndrome ORPHA:261190	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	SCHIP1;PCDH7;RHOBTB3;LIFR;AMOTL2
19p13.3 microduplication syndrome ORPHA:447980	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	FZD1;ZNF703;SETD7;PLSCR4;TIMP2
AA amyloidosis ORPHA:85445	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	IL22RA1;EHF;LAMA3;SNAI2;S100A14
AGel amyloidosis ORPHA:85448	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	GPNMB;TIMP2;CTSD;TGM2;ENG
Alagille syndrome due to 20p12 microdeletion ORPHA:261600	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;CCND1;PLK2;LAMA3;AMOTL2
Alagille syndrome due to a JAG1 point mutation ORPHA:261619	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;CCND1;PLK2;LAMA3;AMOTL2
Alopecia universalis ORPHA:701	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;COL12A1;LAMA3;AMOTL2;S100A14
Alpha-B crystallin-related late-onset myopathy ORPHA:399058	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;PLSCR4;LIFR;SORBS1
Atrichia with papular lesions ORPHA:86819	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;COL12A1;LAMA3;AMOTL2;S100A14
Autosomal dominant palmoplantar keratoderma and congenital alopecia ORPHA:1010	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;LIFR;AMOTL2;GLI2
Autosomal dominant slowed nerve conduction velocity ORPHA:140481	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	PCDH7;COL12A1;LIFR;AMOTL2;GLI2
Bartsocas-Papas syndrome ORPHA:1234	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	IL22RA1;EHF;LAMA3;PRR15;S100A14
Benign familial mesial temporal lobe epilepsy ORPHA:163717	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	IL22RA1;EHF;ITGA2;LAMA3;S100A14
Bilateral frontoparietal polymicrogyria ORPHA:101070	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	EHF;AFAP1L2;PDGFB;SUSD4;KRT23
Bloom syndrome ORPHA:125	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1
CHAND syndrome ORPHA:1401	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	IL22RA1;EHF;LAMA3;PRR15;S100A14
Caffey disease ORPHA:1310	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;SNAI2;AMOTL2;GLI2
Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:199354	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;PLSCR4;SNAI2;AMOTL2
Childhood-onset benign chorea with striatal involvement ORPHA:494541	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	SCHIP1;PCDH7;LIFR;AMOTL2;GLI2
Chronic enteropathy associated with SLCO2A1 gene ORPHA:468641	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;PLSCR4;LAMA3;LIFR;AMOTL2
Congenital alveolar capillary dysplasia ORPHA:210122	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;PLSCR4;SNAI2;GLI2
Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;LIFR;AMOTL2;GLI2
Epidermolysis bullosa simplex due to BP230 deficiency ORPHA:412181	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;PCDH7;COL12A1;LIFR;AMOTL2
Epithelial recurrent erosion dystrophy ORPHA:293381	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	IL22RA1;EHF;ITGA2;LAMA3;S100A14
Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;CCND1;COL12A1;PLSCR4;AMOTL2
Familial generalized lentiginosis ORPHA:231040	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;COL12A1;PLSCR4;LIFR;AMOTL2
Familial mesial temporal lobe epilepsy with febrile seizures ORPHA:165805	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	IL22RA1;EHF;ITGA2;LAMA3;S100A14
Fatal infantile hypertonic myofibrillar myopathy ORPHA:280553	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;PLSCR4;LIFR;SORBS1
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;TIMP2;SNAI2;THBS1
Glutamate-cysteine ligase deficiency ORPHA:33574	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	EHF;ABCC2;PIR;SPAG1;S100A14
HTRA1-related autosomal dominant cerebral small vessel disease ORPHA:482077	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;PLSCR4;SNAI2;AMOTL2
Helicoid peripapillary chorioretinal degeneration ORPHA:86813	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;CCND1;COL12A1;LIFR;AMOTL2
Hereditary sensory and autonomic neuropathy type 6 ORPHA:314381	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;PCDH7;COL12A1;LIFR;AMOTL2
Infantile-onset generalized dyskinesia with orofacial involvement ORPHA:494526	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	SCHIP1;PCDH7;LIFR;AMOTL2;GLI2
Keratolytic winter erythema ORPHA:50943	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	GPNMB;TIMP2;CTSD;TGM2;ENG
Kuskokwim syndrome ORPHA:1149	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	CCND1;COL12A1;COL5A2;AMOTL2;GLI2
Late-onset junctional epidermolysis bullosa ORPHA:79406	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	IL22RA1;EHF;ITGA2;LAMA3;S100A14
Lethal hydranencephaly-diaphragmatic hernia syndrome ORPHA:480528	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;SNAI2;AMOTL2;GLI2
Lymphedema-distichiasis syndrome ORPHA:33001	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;SNAI2;AMOTL2;GLI2
Malan overgrowth syndrome ORPHA:420179	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	FZD1;ZNF703;SETD7;PLSCR4;TIMP2
Marshall-Smith syndrome ORPHA:561	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	FZD1;ZNF703;SETD7;PLSCR4;TIMP2
Metaphyseal chondrodysplasia, Spahr type ORPHA:2501	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	EHF;ITGA2;LAMA3;KRT13;S100A14
Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1
Microcephaly-micromelia syndrome ORPHA:572768	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	CENPE;DEPDC1B;OIP5;CLSPN;SHCBP1
Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	CENPE;DEPDC1B;OIP5;CLSPN;SHCBP1
Microphthalmia with brain and digit anomalies ORPHA:139471	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	ADAMTS15;KITLG;CCND1;COL12A1;AMOTL2
Monoamine oxidase A deficiency ORPHA:3057	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;PLSCR4;LAMA3;LIFR;AMOTL2
Mucopolysaccharidosis type 4A ORPHA:309297	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	OGFR;FRMD8;ALDH3B1;SLC22A18;CTSD
Multiple paragangliomas associated with polycythemia ORPHA:324299	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;PLSCR4;LAMA3;AMOTL2;TGM2
Muscle filaminopathy ORPHA:171445	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;LIFR;AMOTL2;GLI2
NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris ORPHA:462	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;LAMA3;SNAI2;AMOTL2;CPA4
NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;PLSCR4;LIFR;AMOTL2;PBX1
Neuropathy with hearing impairment ORPHA:139512	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	IL22RA1;EHF;LAMA3;KRT13;S100A14
Non-immune hydrops fetalis ORPHA:363999	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;PLSCR4;SNAI2;AMOTL2
Oculodentodigital dysplasia ORPHA:2710	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;LIFR;AMOTL2;GLI2
Optic atrophy-intellectual disability syndrome ORPHA:401777	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;PCDH7;COL12A1;LIFR;AMOTL2
Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome ORPHA:447961	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;COL12A1;PLSCR4;LIFR;AMOTL2
Posterior urethral valve ORPHA:93110	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;SNAI2;GLI2;VGLL3
Primary peritoneal carcinoma ORPHA:168829	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1
Recessive X-linked ichthyosis ORPHA:461	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	NCEH1;SETD7;PLSCR4;RGL1;TRAK2
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	P2RX7;SMIM13;GPNMB;RGL1;SYNE3
Spondyloepimetaphyseal dysplasia, Missouri type ORPHA:93356	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	EHF;ITGA2;LAMA3;KRT13;S100A14
Syndactyly type 3 ORPHA:93404	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	COL12A1;COL5A2;LIFR;AMOTL2;GLI2
Syndromic recessive X-linked ichthyosis ORPHA:281090	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	NCEH1;SETD7;PLSCR4;RGL1;TRAK2
VACTERL with hydrocephalus ORPHA:3412	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1
X-linked Alport syndrome ORPHA:88917	5/101	0.005387359974864572	0.0586579655822394	0	0	4.723982334869432	24.67666564699378	KITLG;PCDH7;COL12A1;LIFR;AMOTL2
Autosomal recessive Robinow syndrome ORPHA:1507	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	ADAMTS15;COL12A1;LIFR;AMOTL2;GLI2
Familial primary hypomagnesemia with normocalciuria and normocalcemia ORPHA:34527	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	TSC22D1;SORT1;MED12L;PBX1;GPR137C
Griscelli syndrome type 3 ORPHA:79478	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	GPNMB;PLK2;ITGA2;COL12A1;SETD7
Juvenile Paget disease ORPHA:2801	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	KITLG;CCND1;ITGA2;COL12A1;LAMA3
Lacrimoauriculodentodigital syndrome ORPHA:2363	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	PCDH7;LIFR;AMOTL2;SORBS1;PBX1
Malignant peripheral nerve sheath tumor ORPHA:3148	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	COL12A1;COL5A2;PLSCR4;SNAI2;AMOTL2
Marie Unna hereditary hypotrichosis ORPHA:444	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	IL22RA1;EHF;LAMA3;PRR15;S100A14
Non-seminomatous germ cell tumor of testis ORPHA:363494	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	KITLG;CCND1;COL12A1;LIFR;AMOTL2
Phakomatosis cesioflammea ORPHA:79483	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	KITLG;SORT1;PLSCR4;LIFR;AMOTL2
Postaxial polydactyly type B ORPHA:93335	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	ADAMTS15;COL12A1;COL5A2;SNAI2;GLI2
Progressive familial intrahepatic cholestasis type 1 ORPHA:79306	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	EHF;ITGA2;LAMA3;PRR15;S100A14
Sclerosteosis ORPHA:3152	5/102	0.005615028303876076	0.0586579655822394	0	0	4.675043945080526	24.227520675921447	PCDH7;COL5A2;LIFR;AMOTL2;GLI2
Brachydactyly type A1 ORPHA:93388	5/103	0.005849405051305985	0.05994247462100228	0	0	4.627104297940375	23.78986494105624	KITLG;COL12A1;SNAI2;LIFR;AMOTL2
Hennekam syndrome ORPHA:2136	5/103	0.005849405051305985	0.05994247462100228	0	0	4.627104297940375	23.78986494105624	COL12A1;COL5A2;SNAI2;LIFR;GLI2
Mosaic variegated aneuploidy syndrome ORPHA:1052	5/103	0.005849405051305985	0.05994247462100228	0	0	4.627104297940375	23.78986494105624	CENPE;DEPDC1B;OIP5;CLSPN;SHCBP1
Osteosarcoma ORPHA:668	5/103	0.005849405051305985	0.05994247462100228	0	0	4.627104297940375	23.78986494105624	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1
Distal hereditary motor neuropathy type 2 ORPHA:139525	5/104	0.006090592174153188	0.06211826710321166	0	0	4.580133128520226	23.3633047289322	COL12A1;COL5A2;SNAI2;AMOTL2;RBM24
Athyreosis ORPHA:95713	5/105	0.006338691039630923	0.0640416108792758	0	0	4.534101382488479	22.947463393069683	CYP24A1;SIX2;ITGA2;LAMA3;CPA4
Familial isolated restrictive cardiomyopathy ORPHA:75249	5/105	0.006338691039630923	0.0640416108792758	0	0	4.534101382488479	22.947463393069683	ADAMTS15;ADPRHL1;AMOTL2;RBM24;GLI2
Combined pituitary hormone deficiencies, genetic forms ORPHA:95494	5/107	0.00685602631553487	0.06830633625477334	0	0	4.44474564019156	22.146510787793925	SCML2;TMSB15A;FGF19;E2F7;GLI2
Osteogenesis imperfecta type 3 ORPHA:216812	5/107	0.00685602631553487	0.06830633625477334	0	0	4.44474564019156	22.146510787793925	COL12A1;COL5A2;SNAI2;AMOTL2;GLI2
Seckel syndrome ORPHA:808	5/107	0.00685602631553487	0.06830633625477334	0	0	4.44474564019156	22.146510787793925	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1
Hirschsprung disease ORPHA:388	5/108	0.00712546221656845	0.07066357000025486	0	0	4.401369066261017	21.76072377674922	PCDH7;COL12A1;COL5A2;LIFR;AMOTL2
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form ORPHA:293899	5/111	0.007978024848328545	0.07839593366942023	0	0	4.276149900008695	20.65835559759507	PCDH7;COL12A1;LAMA3;LIFR;AMOTL2
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form ORPHA:293888	5/111	0.007978024848328545	0.07839593366942023	0	0	4.276149900008695	20.65835559759507	PCDH7;COL12A1;LAMA3;LIFR;AMOTL2
Familial thoracic aortic aneurysm and aortic dissection ORPHA:91387	5/115	0.009221640477709394	0.09020441049104826	0	0	4.119815668202765	19.306289788618034	ACTA2;COL12A1;COL5A2;PLSCR4;SNAI2
Fanconi anemia ORPHA:84	5/116	0.009552258398226163	0.09301565643883575	0	0	4.082492630879727	18.987582068068875	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1
Autosomal recessive primary microcephaly ORPHA:2512	5/119	0.010592899958045469	0.10268432752123356	0	0	3.9744522596814615	18.074105099175988	CENPE;DEPDC1B;ESCO2;CLSPN;SHCBP1
Arthrochalasia Ehlers-Danlos syndrome ORPHA:1899	4/100	0.025345931560966036	0.1590470395003315	0	0	3.7618501529051986	13.825314882957242	ACTA2;COL12A1;COL5A2;SNAI2
Combined immunodeficiency with granulomatosis ORPHA:157949	4/100	0.025345931560966036	0.1590470395003315	0	0	3.7618501529051986	13.825314882957242	CENPE;DEPDC1B;SCML2;E2F7
Ehlers-Danlos/osteogenesis imperfecta syndrome ORPHA:230857	4/100	0.025345931560966036	0.1590470395003315	0	0	3.7618501529051986	13.825314882957242	ACTA2;COL12A1;COL5A2;SNAI2
Osteogenesis imperfecta type 1 ORPHA:216796	4/100	0.025345931560966036	0.1590470395003315	0	0	3.7618501529051986	13.825314882957242	ACTA2;COL12A1;COL5A2;SNAI2
Periodontal Ehlers-Danlos syndrome ORPHA:75392	4/100	0.025345931560966036	0.1590470395003315	0	0	3.7618501529051986	13.825314882957242	ACTA2;COL12A1;COL5A2;PLSCR4
Pleomorphic salivary gland adenoma ORPHA:454821	4/100	0.025345931560966036	0.1590470395003315	0	0	3.7618501529051986	13.825314882957242	CENPE;RPSAP52;CLSPN;E2F7
Severe combined immunodeficiency due to complete RAG1/2 deficiency ORPHA:331206	4/100	0.025345931560966036	0.1590470395003315	0	0	3.7618501529051986	13.825314882957242	CENPE;DEPDC1B;SCML2;E2F7
White sponge nevus ORPHA:171723	4/100	0.025345931560966036	0.1590470395003315	0	0	3.7618501529051986	13.825314882957242	EHF;PADI3;KRT13;S100A14
15q13.3 microdeletion syndrome ORPHA:199318	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ACBD7;DRAXIN;SLC4A8;GPR137C
1p31p32 microdeletion syndrome ORPHA:401986	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	PLSCR4;LIFR;SORBS1;PBX1
21q22.11q22.12 microdeletion syndrome ORPHA:261323	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CENPE;DEPDC1B;CLSPN;SHCBP1
ABeta amyloidosis, Arctic type ORPHA:324723	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;CCND1;PLK2;AMOTL2
ABeta amyloidosis, Dutch type ORPHA:100006	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;CCND1;PLK2;AMOTL2
ABeta amyloidosis, Iowa type ORPHA:324708	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;CCND1;PLK2;AMOTL2
ABeta amyloidosis, Italian type ORPHA:324713	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;CCND1;PLK2;AMOTL2
ABetaA21G amyloidosis ORPHA:324718	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;CCND1;PLK2;AMOTL2
ABetaL34V amyloidosis ORPHA:324703	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;CCND1;PLK2;AMOTL2
Ablepharon macrostomia syndrome ORPHA:920	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;COL5A2;SNAI2;GLI2
Acrogeria ORPHA:2500	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ACTA2;COL12A1;COL5A2;SNAI2
Acromesomelic dysplasia, Hunter-Thompson type ORPHA:968	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	RPSAP52;COL12A1;SNAI2;VGLL3
Adenocarcinoma of ovary ORPHA:213504	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;SNAI2;THBS1;TGM2
Allan-Herndon-Dudley syndrome ORPHA:59	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;COL5A2;LIFR;AMOTL2
Amish nemaline myopathy ORPHA:98902	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	PPP1R14B;ADPRHL1;PADI3;OIP5
Aneurysm-osteoarthritis syndrome ORPHA:284984	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CYP24A1;ITGA2;PRSS23;THBS1
Angel-shaped phalango-epiphyseal dysplasia ORPHA:63442	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	RPSAP52;COL12A1;SNAI2;VGLL3
Autosomal dominant osteopetrosis type 1 ORPHA:2783	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GANAB;CCND1;AMOTL2;SMAD6
Barber-Say syndrome ORPHA:1231	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;COL5A2;SNAI2;GLI2
Brachydactyly-arterial hypertension syndrome ORPHA:1276	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	PLSCR4;LIFR;SORBS1;PBX1
Branchio-oculo-facial syndrome ORPHA:1297	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CCND1;LAMA3;AMOTL2;E2F7
Campomelic dysplasia ORPHA:140	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;CCND1;LIFR;AMOTL2
Carbamoyl-phosphate synthetase 1 deficiency ORPHA:147	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;SNAI2;LIFR;AMOTL2
Carnitine palmitoyl transferase 1A deficiency ORPHA:156	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CASP7;ALDH3B1;ABHD14B;CTSD
Carvajal syndrome ORPHA:65282	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CCND1;LAMA3;AMOTL2;S100A14
Cataract-glaucoma syndrome ORPHA:162	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ADPRHL1;SIX2;WNT9A;RBM24
Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ALDH3B1;SLC22A18;CTSD;ENG
Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ADAMTS15;COL12A1;COL5A2;AMOTL2
Cholangiocarcinoma ORPHA:70567	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	IL22RA1;EHF;LAMA3;S100A14
Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	PLK2;COL12A1;AMOTL2;PRSS23
Combined immunodeficiency due to CD70 deficiency ORPHA:538958	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	TNFSF9;KCNN4;MRM1;MICB
Combined immunodeficiency due to GINS1 deficiency ORPHA:505227	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	DEPDC1B;ESCO2;CLSPN;SHCBP1
Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	HPSE;TLR6;HTATIP2;PSMB9
Complete androgen insensitivity syndrome ORPHA:99429	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;COL5A2;LIFR;PBX1
DNA2-related mitochondrial DNA deletion syndrome ORPHA:352470	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CENPE;DEPDC1B;ESCO2;CLSPN
Denys-Drash syndrome ORPHA:220	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	SCML2;CLSPN;SHCBP1;SPC25
Dicarboxylic aminoaciduria ORPHA:2195	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;COL12A1;LIFR;AMOTL2
Dyssegmental dysplasia, Silverman-Handmaker type ORPHA:1865	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CCND1;COL12A1;COL5A2;AMOTL2
Early-onset Lafora body disease ORPHA:324290	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ZBTB18;CHST11;PDE4B;SYNE3
Endosteal hyperostosis, Worth type ORPHA:2790	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GANAB;CCND1;AMOTL2;SMAD6
Epithelial basement membrane dystrophy ORPHA:98956	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	TIMP2;THBS1;TGM2;ENG
Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CCND1;LAMA3;AMOTL2;S100A14
Familial abdominal aortic aneurysm ORPHA:86	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ACTA2;COL12A1;COL5A2;SNAI2
Familial cavitary optic disc anomaly ORPHA:464760	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GPNMB;THBS1;TGM2;ENG
Familial expansile osteolysis ORPHA:85195	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	IL22RA1;EHF;LAMA3;S100A14
Familial retinal arterial macroaneurysm ORPHA:284247	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ACTA2;PLSCR4;TIMP2;ENG
Familial visceral myopathy ORPHA:2604	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ACTA2;COL12A1;COL5A2;SNAI2
Female restricted epilepsy with intellectual disability ORPHA:101039	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	PCDH7;CHST1;LIFR;PBX1
Fibronectin glomerulopathy ORPHA:84090	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;COL5A2;SNAI2;AMOTL2
Focal facial dermal dysplasia type III ORPHA:1807	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;COL5A2;SNAI2;GLI2
Frasier syndrome ORPHA:347	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	SCML2;CLSPN;SHCBP1;SPC25
Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome ORPHA:306542	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	TMSB15A;ISL1;E2F7;GLI2
Galactose mutarotase deficiency ORPHA:570422	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ACSL5;IQGAP2;SKAP1;PSMB9
Galactosialidosis ORPHA:351	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ALDH3B1;SLC22A18;CTSD;ENG
Generalized glucocorticoid resistance syndrome ORPHA:786	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KAT2B;TLR6;SYNE3;PSMB9
Glutaric acidemia type 3 ORPHA:35706	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;COL5A2;SNAI2;AMOTL2
Granular corneal dystrophy type I ORPHA:98962	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	TIMP2;THBS1;TGM2;ENG
Granular corneal dystrophy type II ORPHA:98963	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	TIMP2;THBS1;TGM2;ENG
Harlequin ichthyosis ORPHA:457	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	EHF;LAMA3;PADI3;S100A14
High myopia-sensorineural deafness syndrome ORPHA:363396	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	EHF;PCDH7;LAMA3;S100A14
Hot water reflex epilepsy ORPHA:166412	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;COL12A1;LIFR;AMOTL2
Hypocalcemic vitamin D-resistant rickets ORPHA:93160	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CASP7;ALDH3B1;HPSE;KCNN4
Hypopigmentation-punctate palmoplantar keratoderma syndrome ORPHA:324561	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CCND1;COL12A1;LIFR;AMOTL2
Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations ORPHA:319462	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CENPE;ESCO2;CLSPN;SHCBP1
Isolated Pierre Robin syndrome ORPHA:718	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;CCND1;LIFR;AMOTL2
Jawad syndrome ORPHA:313795	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CENPE;DEPDC1B;CLSPN;E2F7
Kennedy disease ORPHA:481	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;COL5A2;LIFR;PBX1
Keratoderma hereditarium mutilans ORPHA:494	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	IL22RA1;EHF;LAMA3;S100A14
Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	IL22RA1;EHF;LAMA3;S100A14
LRP5-related primary osteoporosis ORPHA:498481	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GANAB;CCND1;AMOTL2;SMAD6
Lateral meningocele syndrome ORPHA:2789	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ADAMTS15;COL12A1;COL5A2;AMOTL2
Lattice corneal dystrophy type I ORPHA:98964	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	TIMP2;THBS1;TGM2;ENG
Lipoid proteinosis ORPHA:530	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GPNMB;COL12A1;SNAI2;ENG
Lymphedema-posterior choanal atresia syndrome ORPHA:99141	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;SNAI2;AMOTL2;GLI2
MITF-related melanoma and renal cell carcinoma predisposition syndrome ORPHA:293822	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GPNMB;PLSCR4;ME1;TGM2
Meacham syndrome ORPHA:3097	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	SCML2;CLSPN;SHCBP1;SPC25
Microcephaly-complex motor and sensory axonal neuropathy syndrome ORPHA:423894	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CENPE;DEPDC1B;ESCO2;CLSPN
Microduplication Xp11.22p11.23 syndrome ORPHA:217377	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ADAM15;ZNF703;TIMP2;FAM219A
Monilethrix ORPHA:573	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	IL22RA1;CYP24A1;PADI3;S100A14
Multiple myeloma ORPHA:29073	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;CCND1;COL12A1;AMOTL2
Myopathic intestinal pseudoobstruction ORPHA:104077	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ACTA2;COL12A1;COL5A2;SNAI2
NON RARE IN EUROPE: Non rare obesity ORPHA:521399	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ACBD7;CNTNAP2;EFR3B;GPR137C
Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	IL22RA1;EHF;LAMA3;S100A14
Osteoporosis-pseudoglioma syndrome ORPHA:2788	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GANAB;CCND1;AMOTL2;SMAD6
Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GANAB;CCND1;AMOTL2;SMAD6
Partial androgen insensitivity syndrome ORPHA:90797	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;COL5A2;LIFR;PBX1
Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	IL22RA1;EHF;LAMA3;S100A14
Progressive familial intrahepatic cholestasis type 4 ORPHA:480483	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ITGA2;LAMA3;AMOTL2;S100A14
Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome ORPHA:228012	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	KITLG;CCND1;LIFR;AMOTL2
Pycnodysostosis ORPHA:763	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ACTA2;GPNMB;TIMP2;ENG
Reis-Bucklers corneal dystrophy ORPHA:98961	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	TIMP2;THBS1;TGM2;ENG
Ring dermoid of cornea ORPHA:91481	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;SNAI2;AMOTL2;GLI2
Sanfilippo syndrome type D ORPHA:79272	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	FZD1;TIMP2;CTSD;SUMF1
Schwartz-Jampel syndrome ORPHA:800	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CCND1;COL12A1;COL5A2;AMOTL2
Serrated polyposis syndrome ORPHA:157798	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	SULT1A1;LPAR5;SORL1;SKAP1
Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ADAM15;ZNF703;TIMP2;FAM219A
Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	CCND1;LAMA3;AMOTL2;S100A14
Spinocerebellar ataxia type 1 ORPHA:98755	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	P2RX7;KAT2B;SYNE3;CPEB4
Split hand-split foot-deafness syndrome ORPHA:71271	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	PCDH7;SNAI2;AMOTL2;ISL1
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome ORPHA:93358	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;COL5A2;SNAI2;LIFR
Stuve-Wiedemann syndrome ORPHA:3206	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	PCDH7;COL12A1;LIFR;AMOTL2
Tay-Sachs disease, B variant, adult form ORPHA:309192	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GPNMB;NEU1;CTSD;SUMF1
Tay-Sachs disease, B variant, infantile form ORPHA:309178	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GPNMB;NEU1;CTSD;SUMF1
Tay-Sachs disease, B variant, juvenile form ORPHA:309185	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GPNMB;NEU1;CTSD;SUMF1
Tay-Sachs disease, B1 variant ORPHA:309239	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GPNMB;NEU1;CTSD;SUMF1
Thiel-Behnke corneal dystrophy ORPHA:98960	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	TIMP2;THBS1;TGM2;ENG
Tietz syndrome ORPHA:42665	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GPNMB;PLSCR4;ME1;TGM2
Trehalase deficiency ORPHA:103909	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	COL12A1;PLSCR4;LIFR;AMOTL2
Vascular Ehlers-Danlos syndrome ORPHA:286	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ACTA2;COL12A1;COL5A2;SNAI2
X-linked adrenal hypoplasia congenita ORPHA:95702	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	GPR37;SCG2;GLI2;C1QL1
X-linked hypophosphatemia ORPHA:89936	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ITGA2;SPAG1;PRSS23;CPA4
Xanthinuria type I ORPHA:93601	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	IL22RA1;EHF;LAMA3;S100A14
Xeroderma pigmentosum variant ORPHA:90342	4/101	0.026168966766461996	0.1590470395003315	0	0	3.722879031495318	13.563122319709116	ESCO2;CLSPN;SHCBP1;E2F7
Acromesomelic dysplasia, Grebe type ORPHA:2098	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	COL12A1;SNAI2;LIFR;AMOTL2
Autosomal recessive hypophosphatemic rickets ORPHA:289176	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	CCND1;COL12A1;LIFR;AMOTL2
Bladder exstrophy ORPHA:93930	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	LAMA3;KRT13;S100A14;ISL1
Blepharo-cheilo-odontic syndrome ORPHA:1997	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	EHF;LAMA3;PRR15;S100A14
Brachydactyly type C ORPHA:93384	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	COL12A1;SNAI2;LIFR;AMOTL2
Enlarged parietal foramina ORPHA:60015	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	ADAMTS15;AMOTL2;SMAD6;GLI2
Familial calcium pyrophosphate deposition ORPHA:1416	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	ACTA2;GPNMB;COL12A1;PLSCR4
Familial patent arterial duct ORPHA:466729	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	PCDH7;LIFR;AMOTL2;PBX1
Fibular aplasia-complex brachydactyly syndrome ORPHA:2639	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	COL12A1;SNAI2;LIFR;AMOTL2
Hereditary mixed polyposis syndrome ORPHA:157794	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	COL12A1;COL5A2;GLI2;VGLL3
Hyperostosis corticalis generalisata ORPHA:3416	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	ADAMTS15;CCND1;AMOTL2;SMAD6
Isolated ectopia lentis ORPHA:1885	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	ACTA2;COL12A1;COL5A2;ENG
Palmoplantar keratoderma-deafness syndrome ORPHA:2202	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	IL22RA1;EHF;LAMA3;S100A14
Pfeiffer syndrome type 1 ORPHA:93258	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	LIFR;AMOTL2;PBX1;GLI2
Severe dermatitis-multiple allergies-metabolic wasting syndrome ORPHA:369992	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	IL22RA1;EHF;LAMA3;S100A14
Shprintzen-Goldberg syndrome ORPHA:2462	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	CNTNAP1;COL12A1;COL5A2;TIMP2
Silver-Russell syndrome due to 11p15 microduplication ORPHA:231144	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	COL5A2;PLSCR4;LIFR;AMOTL2
Silver-Russell syndrome due to an imprinting defect of 11p15 ORPHA:231140	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	COL5A2;PLSCR4;LIFR;AMOTL2
Solitary fibrous tumor/hemangiopericytoma ORPHA:2126	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	OGFR;FRMD8;KCNN4;ENG
Spondylometaphyseal dysplasia, 'corner fracture' type ORPHA:93315	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	COL5A2;LIFR;AMOTL2;GLI2
Uncombable hair syndrome ORPHA:1410	4/102	0.027007904361999933	0.1590470395003315	0	0	3.684703239093803	13.307768921351867	PADI3;KRT13;KRT23;S100A14
Acrocallosal syndrome ORPHA:36	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	ADAMTS15;COL5A2;AMOTL2;GLI2
Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 ORPHA:231117	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	COL5A2;PLSCR4;LIFR;AMOTL2
Butterfly-shaped pigment dystrophy ORPHA:99001	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	LIFR;AMOTL2;PBX1;GLI2
Complete atrioventricular septal defect with ventricular hypoplasia ORPHA:99067	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	CCND1;LIFR;AMOTL2;SMAD6
Idiopathic juvenile osteoporosis ORPHA:85193	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	BFSP1;CYP24A1;PADI3;WNT9A
Isolated aniridia ORPHA:250923	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	PCDH7;RHOBTB3;LIFR;AMOTL2
Isolated hemihyperplasia ORPHA:2128	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	COL5A2;PLSCR4;LIFR;AMOTL2
Mutilating palmoplantar keratoderma with periorificial keratotic plaques ORPHA:659	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	CCND1;COL12A1;LAMA3;AMOTL2
NON RARE IN EUROPE: Ventricular septal defect ORPHA:1480	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	ADAMTS15;SMAD6;RBM24;GLI2
Partial atrioventricular septal defect ORPHA:1330	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	CCND1;LIFR;AMOTL2;SMAD6
Persistent hyperplastic primary vitreous ORPHA:91495	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	KITLG;GPR37;LIFR;AMOTL2
Retinopathy of prematurity ORPHA:90050	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	KITLG;CCND1;LIFR;AMOTL2
WAGR syndrome ORPHA:893	4/103	0.027862794559305282	0.1590470395003315	0	0	3.6472986748216107	13.059017985913899	SCHIP1;SCG2;GLI2;C1QL1
Congenital glaucoma ORPHA:98976	4/104	0.028733683989797268	0.16144879359280342	0	0	3.6106422018348625	12.816643136643854	ACTA2;COL12A1;COL5A2;PLSCR4
Epithelioid hemangioendothelioma ORPHA:157791	4/104	0.028733683989797268	0.16144879359280342	0	0	3.6106422018348625	12.816643136643854	CCND1;COL12A1;LIFR;AMOTL2
Familial progressive cardiac conduction defect ORPHA:871	4/104	0.028733683989797268	0.16144879359280342	0	0	3.6106422018348625	12.816643136643854	ADPRHL1;AMOTL2;SMAD6;RBM24
Isolated brachycephaly ORPHA:35099	4/104	0.028733683989797268	0.16144879359280342	0	0	3.6106422018348625	12.816643136643854	COL5A2;LIFR;AMOTL2;GLI2
Isolated plagiocephaly ORPHA:35098	4/104	0.028733683989797268	0.16144879359280342	0	0	3.6106422018348625	12.816643136643854	COL5A2;LIFR;AMOTL2;GLI2
Li-Fraumeni syndrome ORPHA:524	4/104	0.028733683989797268	0.16144879359280342	0	0	3.6106422018348625	12.816643136643854	ESCO2;CLSPN;SHCBP1;E2F7
Ear-patella-short stature syndrome ORPHA:2554	4/105	0.029620615744375748	0.16599886740077244	0	0	3.574711599600327	12.58042777586237	DEPDC1B;ESCO2;CLSPN;SHCBP1
Autosomal dominant polycystic kidney disease ORPHA:730	4/106	0.03052362937350739	0.1697334635963512	0	0	3.5394855189782337	12.350164577592135	GANAB;COL12A1;COL5A2;AMOTL2
Bilateral striopallidodentate calcinosis ORPHA:1980	4/106	0.03052362937350739	0.1697334635963512	0	0	3.5394855189782337	12.350164577592135	COL5A2;PDGFB;LIFR;SORBS1
Hypoplastic amelogenesis imperfecta ORPHA:100031	4/106	0.03052362937350739	0.1697334635963512	0	0	3.5394855189782337	12.350164577592135	IL22RA1;EHF;KRT13;S100A14
Early-onset autosomal dominant Alzheimer disease ORPHA:1020	4/107	0.03144276093078895	0.17394555661454453	0	0	3.5049434399216177	12.125655005955236	OGFR;ADAM15;CTSD;SORL1
NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279	4/107	0.03144276093078895	0.17394555661454453	0	0	3.5049434399216177	12.125655005955236	COL12A1;COL5A2;PLSCR4;SNAI2
Colobomatous microphthalmia ORPHA:98938	4/108	0.032378042991406744	0.1782034488938806	0	0	3.4710656316160904	11.906708865891195	COL5A2;LIFR;AMOTL2;GLI2
Heritable pulmonary arterial hypertension ORPHA:275777	4/108	0.032378042991406744	0.1782034488938806	0	0	3.4710656316160904	11.906708865891195	COL12A1;COL5A2;PLSCR4;ENG
Hereditary breast and ovarian cancer syndrome ORPHA:145	4/111	0.035281066412520615	0.19368585438710295	0	0	3.373231587070222	11.281465475708032	CENPE;ESCO2;CLSPN;SHCBP1
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form ORPHA:293910	4/112	0.03628120770492872	0.19816537812438226	0	0	3.341828066598709	11.083023623186925	PCDH7;COL12A1;LIFR;AMOTL2
Familial prostate cancer ORPHA:1331	4/112	0.03628120770492872	0.19816537812438226	0	0	3.341828066598709	11.083023623186925	CENPE;ESCO2;CLSPN;SHCBP1
Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635	4/145	0.07834089864327068	0.37620146301579177	0	0	2.5554037347908127	6.507809586277271	KITLG;CCND1;LAMA3;AMOTL2
Bethlem myopathy ORPHA:610	3/100	0.1001333284999847	0.37620146301579177	0	0	2.7794096878971897	6.396124037643629	COL12A1;COL5A2;SNAI2
Congenital muscular dystrophy, Ullrich type ORPHA:75840	3/100	0.1001333284999847	0.37620146301579177	0	0	2.7794096878971897	6.396124037643629	COL12A1;COL5A2;SNAI2
Lethal acantholytic erosive disorder ORPHA:158687	3/100	0.1001333284999847	0.37620146301579177	0	0	2.7794096878971897	6.396124037643629	LAMA3;PRR15;S100A14
Multicentric osteolysis-nodulosis-arthropathy spectrum ORPHA:371428	3/100	0.1001333284999847	0.37620146301579177	0	0	2.7794096878971897	6.396124037643629	COL12A1;COL5A2;SNAI2
Partial pancreatic agenesis ORPHA:2805	3/100	0.1001333284999847	0.37620146301579177	0	0	2.7794096878971897	6.396124037643629	FGF19;ISL1;C1QL1
5-oxoprolinase deficiency ORPHA:33572	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ADAM15;SLC22A18;CTSD
ACys amyloidosis ORPHA:100008	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ZNF703;TIMP2;CTSD
Acatalasemia ORPHA:926	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ACSL5;ABHD14B;PSMB9
Action myoclonus-renal failure syndrome ORPHA:163696	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	KITLG;TIMP2;AMOTL2
Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SULT1A1;FRAT2;MYO15B
Acute neonatal citrullinemia type I ORPHA:247546	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	KITLG;LAMA3;AMOTL2
Adult-onset citrullinemia type I ORPHA:247573	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	KITLG;LAMA3;AMOTL2
Alagille syndrome due to a NOTCH2 point mutation ORPHA:261629	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SETD7;TIMP2;THBS1
Amyloidosis cutis dyschromia ORPHA:319635	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GPNMB;RGL1;ENG
Apparent mineralocorticoid excess ORPHA:320	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	IL22RA1;PRR15;S100A14
Aromatase deficiency ORPHA:91	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	KITLG;GPNMB;PIR
Aromatase excess syndrome ORPHA:178345	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	KITLG;GPNMB;PIR
Arterial tortuosity syndrome ORPHA:3342	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;AMOTL2
Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome ORPHA:1154	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SCHIP1;COL5A2;LIFR
Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome ORPHA:370022	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	PCDH7;LIFR;GLI2
Atelosteogenesis type I ORPHA:1190	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;LAMA3;AMOTL2
Atelosteogenesis type III ORPHA:56305	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;LAMA3;AMOTL2
Athabaskan brainstem dysgenesis syndrome ORPHA:69739	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	TNFSF9;SHCBP1;APOBEC3B
Atrial septal defect, sinus venosus type ORPHA:99105	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	FZD1;FAM43A;SMAD7
Attenuated Chediak-Higashi syndrome ORPHA:352723	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	P2RX7;KAT2B;SYNE3
Autosomal dominant Charcot-Marie-Tooth disease type 2V ORPHA:447964	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GANAB;ADAM15;CTSD
Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome ORPHA:314404	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CENPE;CLSPN;SHCBP1
Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;SNAI2;AMOTL2
Autosomal dominant intermediate Charcot-Marie-Tooth disease type F ORPHA:352670	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	DOCK11;CHST11;OSTM1
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency ORPHA:404499	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	P2RX7;CORO1A;CD22
Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form ORPHA:89842	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;SNAI2;AMOTL2
Autosomal recessive omodysplasia ORPHA:93329	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL5A2;LIFR;AMOTL2
Autosomal recessive spastic paraplegia type 35 ORPHA:171629	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	EHF;PRR15;S100A14
Autosomal recessive spastic paraplegia type 5A ORPHA:100986	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	PLSCR4;SORBS1;RGL1
Autosomal spastic paraplegia type 58 ORPHA:397946	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;COL12A1;AMOTL2
Autosomal spastic paraplegia type 72 ORPHA:401849	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ZCCHC12;EFR3B;C1QL1
BVES-related limb-girdle muscular dystrophy ORPHA:476084	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SCHIP1;RBM24;VGLL3
Becker muscular dystrophy ORPHA:98895	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SCHIP1;LIFR;SORBS1
Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4 ORPHA:119	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL5A2;AMOTL2;RBM24
Bilateral microtia-deafness-cleft palate syndrome ORPHA:140963	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	RPSAP52;ZNF703;SNAI2
Boomerang dysplasia ORPHA:1263	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;LAMA3;AMOTL2
Bosley-Salih-Alorainy syndrome ORPHA:69737	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	TNFSF9;SHCBP1;APOBEC3B
Brachydactyly type B1 ORPHA:572385	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ADAMTS15;COL12A1;GLI2
Brain-lung-thyroid syndrome ORPHA:209905	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SIX2;ELFN2;ISL1
Butyrylcholinesterase deficiency ORPHA:132	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GPR37;COL5A2;LIFR
CLN10 disease ORPHA:228337	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ADAM15;SLC22A18;CTSD
Calpain-3-related  limb-girdle muscular dystrophy R1 ORPHA:267	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	P2RX7;KAT2B;MYO15B
Cardiac-valvular Ehlers-Danlos syndrome ORPHA:230851	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ACTA2;COL12A1;COL5A2
Chediak-Higashi syndrome ORPHA:167	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	P2RX7;KAT2B;SYNE3
Charcot-Marie-Tooth disease type 2R ORPHA:397968	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	PCDH7;LIFR;AMOTL2
Charcot-Marie-Tooth disease type 4C ORPHA:99949	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SCHIP1;ITGA2;CPA4
Chondrodysplasia-disorder of sex development syndrome ORPHA:1422	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	FZD1;CASP7;PLK2
Christianson syndrome ORPHA:85278	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SMIM13;B3GLCT;CCSAP
Chudley-McCullough syndrome ORPHA:314597	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CENPE;DEPDC1B;ESCO2
Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome ORPHA:508476	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GANAB;PPP1R14B;ADAM15
Combined immunodeficiency due to Moesin deficiency ORPHA:504530	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	DOCK11;CHST11;TLR6
Complement component 3 deficiency ORPHA:280133	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GPNMB;PLSCR4;TGM2
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SLC22A18;NEU1;CTSD
Congenital bile acid synthesis defect type 1 ORPHA:79301	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GPNMB;SLC22A18;CTSD
Congenital bile acid synthesis defect type 3 ORPHA:79302	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	PLSCR4;SORBS1;RGL1
Congenital hereditary endothelial dystrophy type I ORPHA:98975	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	EHF;PRR15;S100A14
Congenital non-communicating hydrocephalus ORPHA:269510	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	IQGAP2;CORO1A;SKAP1
Congenital vertical talus, bilateral ORPHA:295203	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;SNAI2;GLI2
Congenital vertical talus, unilateral ORPHA:295201	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;SNAI2;GLI2
Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	DEPDC1B;OIP5;CLSPN
Craniodiaphyseal dysplasia ORPHA:1513	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	P3H2;SNAI2;GLI2
Craniofacial dysplasia-osteopenia syndrome ORPHA:314555	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;SIX2;AMOTL2
Curry-Jones syndrome ORPHA:1553	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL5A2;AMOTL2;GLI2
Deafness-lymphedema-leukemia syndrome ORPHA:3226	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GAL;SMAD6;NRGN
Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;SNAI2;AMOTL2
EMILIN-1-related connective tissue disease ORPHA:485418	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ACTA2;COL5A2;ENG
Embryonal rhabdomyosarcoma ORPHA:99757	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ALDH3B1;SLC22A18;CTSD
Epidermolysis bullosa simplex with circinate migratory erythema ORPHA:158681	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	EHF;KRT13;S100A14
Familial atypical multiple mole melanoma syndrome ORPHA:404560	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	TNFSF9;TRIB3;E2F7
Familial isolated trichomegaly ORPHA:411788	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	RPSAP52;CPA4;VGLL3
Fatty acid hydroxylase-associated neurodegeneration ORPHA:329308	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	EHF;PRR15;S100A14
Fetal Gaucher disease ORPHA:85212	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ADAM15;NEU1;CTSD
Fibrodysplasia ossificans progressiva ORPHA:337	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	PLSCR4;TIMP2;THBS1
Frank-Ter Haar syndrome ORPHA:137834	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	KITLG;CCND1;AMOTL2
Free sialic acid storage disease, infantile form ORPHA:309324	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	OSTM1;NEU1;SUMF1
Fried syndrome ORPHA:85335	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	DOCK11;OSTM1;KBTBD8
Frontonasal dysplasia-alopecia-genital anomalies syndrome ORPHA:228390	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	LIFR;SMAD6;GLI2
GM3 synthase deficiency ORPHA:370933	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	P2RX7;KAT2B;PDE4B
Gaucher disease type 2 ORPHA:77260	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ADAM15;NEU1;CTSD
Gaucher disease type 3 ORPHA:77261	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ADAM15;NEU1;CTSD
Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome ORPHA:2072	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ADAM15;NEU1;CTSD
Gelatinous drop-like corneal dystrophy ORPHA:98957	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	EHF;KRT13;S100A14
Genetic transient congenital hypothyroidism ORPHA:226316	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	IL22RA1;EHF;S100A14
Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome ORPHA:2084	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;SNAI2
Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	DEPDC1B;NOLC1;OIP5
Glucose-galactose malabsorption ORPHA:35710	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	IL22RA1;EHF;S100A14
Glycogen storage disease due to acid maltase deficiency, infantile onset ORPHA:308552	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	OGFR;ADAM15;CTSD
Glycogen storage disease due to acid maltase deficiency, late-onset ORPHA:420429	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	OGFR;ADAM15;CTSD
Glycogen storage disease due to muscle and heart glycogen synthase deficiency ORPHA:137625	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GANAB;ADAM15;ZBTB45
Goldberg-Shprintzen megacolon syndrome ORPHA:66629	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	KITLG;AMOTL2;RBM24
Gordon syndrome ORPHA:376	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SCHIP1;COL5A2;LIFR
Growth delay due to insulin-like growth factor I resistance ORPHA:73273	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SORT1;AMOTL2;PBX1
Haim-Munk syndrome ORPHA:2342	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	HPSE;TLR6;PSMB9
Hajdu-Cheney syndrome ORPHA:955	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SETD7;TIMP2;THBS1
Hartsfield syndrome ORPHA:2117	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL5A2;AMOTL2;GLI2
Hereditary sensory neuropathy-deafness-dementia syndrome ORPHA:456318	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CENPE;CLSPN;SHCBP1
High bone mass osteogenesis imperfecta ORPHA:314029	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;SNAI2
Hydranencephaly ORPHA:2177	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	FRMD8;TLR6;MICB
Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ELFN2;SCG2;C1QL1
Intermediate severe Salla disease ORPHA:309331	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	OSTM1;NEU1;SUMF1
Isolated biliary atresia ORPHA:30391	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;COL12A1;AMOTL2
Isolated congenital breast hypoplasia/aplasia ORPHA:180188	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;LIFR;AMOTL2
LIMS2-related limb-girdle muscular dystrophy ORPHA:466801	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ACTA2;TIMP2;ENG
Laminin subunit alpha 2-related congenital muscular dystrophy ORPHA:258	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;PLSCR4
Larsen syndrome ORPHA:503	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;LAMA3;AMOTL2
Legius syndrome ORPHA:137605	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	KITLG;CCND1;AMOTL2
Localized dystrophic epidermolysis bullosa, acral form ORPHA:158673	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;SNAI2;AMOTL2
Localized dystrophic epidermolysis bullosa, nails only ORPHA:158676	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;SNAI2;AMOTL2
Localized dystrophic epidermolysis bullosa, pretibial form ORPHA:79410	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;SNAI2;AMOTL2
MASA syndrome ORPHA:2466	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ELFN2;SCG2;C1QL1
MUC1-related autosomal dominant tubulointerstitial kidney disease ORPHA:88949	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	EHF;PRR15;S100A14
MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	EHF;LAMA3;S100A14
Male infertility with teratozoospermia due to single gene mutation ORPHA:399808	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SMIM13;SCHIP1;EFR3B
Malignant epithelial tumor of salivary glands ORPHA:276145	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL5A2;LIFR;AMOTL2
Marden-Walker syndrome ORPHA:2461	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SCHIP1;COL5A2;LIFR
Marfan syndrome type 1 ORPHA:284963	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;SNAI2
Melanoma and neural system tumor syndrome ORPHA:252206	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	TNFSF9;TRIB3;E2F7
Metopic ridging-ptosis-facial dysmorphism syndrome ORPHA:502430	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	PCDH7;LIFR;AMOTL2
Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome ORPHA:521445	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;SNAI2
Microtia ORPHA:83463	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	RPSAP52;ZNF703;SNAI2
Mitochondrial DNA depletion syndrome, myopathic form ORPHA:254875	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ALDH3B1;TIMP2;SUMF1
Monocytopenia with susceptibility to infections ORPHA:228423	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GAL;SMAD6;NRGN
Mowat-Wilson syndrome due to a ZEB2 point mutation ORPHA:261552	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	P2RX7;DOCK11;PDE4B
Mowat-Wilson syndrome due to monosomy 2q22 ORPHA:261537	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	P2RX7;DOCK11;PDE4B
Multiple epiphyseal dysplasia type 5 ORPHA:93311	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;COL12A1;AMOTL2
Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement ORPHA:168953	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL5A2;AMOTL2;GLI2
NDE1-related microhydranencephaly ORPHA:443162	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	FRMD8;TLR6;MICB
NON RARE IN EUROPE: Parkinson disease ORPHA:319705	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ADAM15;NEU1;CTSD
Naxos disease ORPHA:34217	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ADAM15;PRR15;S100A14
Neonatal Marfan syndrome ORPHA:284979	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;SNAI2
Neutral lipid storage myopathy ORPHA:98908	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	OGFR;MKNK2;CTSD
Osteoglosphonic dysplasia ORPHA:2645	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL5A2;AMOTL2;GLI2
Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ALDH3B1;TLR6;PSMB9
Palmoplantar keratoderma, Nagashima type ORPHA:140966	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ITGA2;SNAI2;CPA4
Papillon-Lefevre ORPHA:678	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	HPSE;TLR6;PSMB9
Pelviscapular dysplasia ORPHA:93333	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;SNAI2
Peroxisomal acyl-CoA oxidase deficiency ORPHA:2971	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	HSDL2;CYP4F2;CPEB4
Pierson syndrome ORPHA:2670	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;COL12A1;AMOTL2
Primary dystonia, DYT27 type ORPHA:464440	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ACTA2;COL12A1;COL5A2
Progeroid and marfanoid aspect-lipodystrophy syndrome ORPHA:300382	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;SNAI2
RFVT3-related riboflavin transporter deficiency ORPHA:572550	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	EHF;PRR15;S100A14
Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;SNAI2;AMOTL2
Renal pseudohypoaldosteronism type 1 ORPHA:171871	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	KAT2B;ABCB1;LRIG1
Salla disease ORPHA:309334	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	OSTM1;NEU1;SUMF1
Sanfilippo syndrome type B ORPHA:79270	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GANAB;ADAM15;CTSD
Scalp-ear-nipple syndrome ORPHA:2036	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	GPR37;PCDH7;AMOTL2
Sebocystomatosis ORPHA:841	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	LAMA3;KRT13;S100A14
Self-improving dystrophic epidermolysis bullosa ORPHA:79411	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;SNAI2;AMOTL2
Sjogren-Larsson syndrome ORPHA:816	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	KITLG;LAMA3;AMOTL2
Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CNTNAP1;FAM219A;LZTS1
Spinocerebellar ataxia type 27 ORPHA:98764	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	PLSCR4;LIFR;SCG2
Spinocerebellar ataxia type 40 ORPHA:423275	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	IQGAP2;CORO1A;SKAP1
Spondyloepimetaphyseal dysplasia, matrilin-3 type ORPHA:156728	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	CCND1;COL12A1;AMOTL2
Stiff skin syndrome ORPHA:2833	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;SNAI2
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A ORPHA:308386	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL5A2;LIFR;AMOTL2
Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers ORPHA:206546	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	SCHIP1;LIFR;SORBS1
Triglyceride deposit cardiomyovasculopathy ORPHA:565612	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	OGFR;MKNK2;CTSD
Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ALDH3B1;SLC22A18;CTSD
X-linked complicated corpus callosum dysgenesis ORPHA:1497	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ELFN2;SCG2;C1QL1
X-linked complicated spastic paraplegia type 1 ORPHA:306617	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	ELFN2;SCG2;C1QL1
X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome ORPHA:1568	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	DOCK11;OSTM1;KBTBD8
X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome ORPHA:85329	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	DOCK11;OSTM1;KBTBD8
X-linked spondyloepimetaphyseal dysplasia ORPHA:93349	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	COL12A1;COL5A2;PLSCR4
Xanthinuria type II ORPHA:93602	3/101	0.1023975452037946	0.37620146301579177	0	0	2.750908582611127	6.269025045162814	IL22RA1;ITGA2;LAMA3
Acrodysostosis ORPHA:950	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	KAT2B;CPEB4;TRAK2
Acrodysostosis with multiple hormone resistance ORPHA:280651	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	KAT2B;CPEB4;TRAK2
Acromicric dysplasia ORPHA:969	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	COL12A1;COL5A2;PLSCR4
Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	GPNMB;PLSCR4;TGM2
Autosomal recessive polycystic kidney disease ORPHA:731	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	COL12A1;LIFR;AMOTL2
Bifid uvula ORPHA:99771	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	PADI3;KRT13;S100A14
Bradyopsia ORPHA:75374	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	ACBD7;EFR3B;GPR137C
Cleft hard palate ORPHA:101023	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	PADI3;KRT13;S100A14
Cleft velum ORPHA:99772	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	PADI3;KRT13;S100A14
Coats plus syndrome ORPHA:313838	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	STN1;DNHD1;CORO1A
Combined immunodeficiency with faciooculoskeletal anomalies ORPHA:221139	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	CLSPN;SHCBP1;MICB
Congenital ptosis ORPHA:91411	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	PCDH7;LIFR;GLI2
Craniometaphyseal dysplasia ORPHA:1522	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	COL12A1;COL5A2;PLSCR4
Dominant hypophosphatemia with nephrolithiasis or osteoporosis ORPHA:244305	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	CYP4F2;SLC22A18;ABHD14B
Fibrochondrogenesis ORPHA:2021	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	CNTNAP1;COL5A2;GLI2
Gaucher disease type 1 ORPHA:77259	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	ADAM15;TIMP2;CTSD
Hereditary sensory and autonomic neuropathy type 5 ORPHA:64752	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	ADAMTS14;SNAI2;GLI2
Meesmann corneal dystrophy ORPHA:98954	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	IL22RA1;KRT13;S100A14
Microvillus inclusion disease ORPHA:2290	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	EHF;PRR15;S100A14
Niemann-Pick disease type C, adult neurologic onset ORPHA:216986	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	GPNMB;NEU1;CTSD
Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	GPNMB;NEU1;CTSD
Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	GPNMB;NEU1;CTSD
Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	GPNMB;NEU1;CTSD
Niemann-Pick disease type C, severe perinatal form ORPHA:216972	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	GPNMB;NEU1;CTSD
Oculootodental syndrome ORPHA:99806	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	PPP1R14B;FGF19;BBC3
Proximal symphalangism ORPHA:3250	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	RPSAP52;CPA4;VGLL3
Renal hypoplasia, bilateral ORPHA:97362	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	LIFR;PBX1;GLI2
Submucosal cleft palate ORPHA:155878	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	PADI3;KRT13;S100A14
Tetraamelia-multiple malformations syndrome ORPHA:3301	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	GPR37;LIFR;SCG2
Truncus arteriosus ORPHA:3384	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	TIMP2;SMAD6;ENG
X-linked myotubular myopathy-abnormal genitalia syndrome ORPHA:456328	3/102	0.10468208130287412	0.37620146301579177	0	0	2.7229832572298327	6.145303004072325	KAT2B;ARL2BP;TRAK2
Alopecia-intellectual disability syndrome ORPHA:2850	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	IL22RA1;AMOTL2;S100A14
Autosomal dominant cutis laxa ORPHA:90348	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	ACTA2;COL12A1;COL5A2
Complete atrioventricular septal defect-tetralogy of Fallot ORPHA:99068	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	CCND1;LIFR;AMOTL2
Dehydrated hereditary stomatocytosis ORPHA:3202	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	FRMD8;TLR6;KCNN4
Dysosteosclerosis ORPHA:1782	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	SLC22A18;KCNN4;CTSD
Ellis Van Creveld syndrome ORPHA:289	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	COL5A2;SNAI2;GLI2
Familial vesicoureteral reflux ORPHA:289365	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	PLSCR4;LIFR;SORBS1
Geleophysic dysplasia ORPHA:2623	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	ACTA2;COL12A1;COL5A2
Hereditary diffuse gastric cancer ORPHA:26106	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	LAMA3;AMOTL2;S100A14
Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	CNTNAP1;LIFR;AMOTL2
Keratosis follicularis spinulosa decalvans ORPHA:2340	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	GPNMB;TIMP2;RGL1
Milroy disease ORPHA:79452	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	COL12A1;COL5A2;AMOTL2
NON RARE IN EUROPE: Infantile capillary hemangioma ORPHA:464293	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	COL5A2;LIFR;AMOTL2
NON RARE IN EUROPE: Paget disease of bone ORPHA:280110	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	OGFR;ADAM15;CTSD
Rolandic epilepsy ORPHA:1945	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	SCHIP1;PCDH7;SCG2
Saethre-Chotzen syndrome ORPHA:794	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	PCDH7;LIFR;AMOTL2
Weill-Marchesani syndrome ORPHA:3449	3/103	0.10698666141527163	0.37620146301579177	0	0	2.6956164383561645	6.0248405179689755	ACTA2;COL12A1;COL5A2
Aplasia cutis congenita ORPHA:1114	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	CCND1;LAMA3;AMOTL2
Autosomal recessive hypohidrotic ectodermal dysplasia ORPHA:248	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	LAMP3;ZBED2;SKAP1
Cleft lip and alveolus ORPHA:141291	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	EHF;LAMA3;S100A14
Familial bicuspid aortic valve ORPHA:402075	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	ADAMTS15;SMAD6;GLI2
Hypocalcified amelogenesis imperfecta ORPHA:100032	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	EHF;KRT13;S100A14
ICF syndrome ORPHA:2268	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	CENPE;DEPDC1B;CLSPN
Isolated cleft lip ORPHA:199302	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	EHF;LAMA3;S100A14
Primary pigmented nodular adrenocortical disease ORPHA:189439	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	SORT1;SORBS1;CPEB4
Renal agenesis, bilateral ORPHA:1848	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	PCDH7;LIFR;PBX1
Severe early-childhood-onset retinal dystrophy ORPHA:364055	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	SCHIP1;PCDH7;LIFR
Weaver syndrome ORPHA:3447	3/104	0.1093110087392664	0.37758794672054785	0	0	2.6687915366879156	5.9075253059944925	CENPE;ESCO2;CLSPN
Familial cerebral saccular aneurysm ORPHA:231160	3/105	0.11165484528789996	0.38261341888465084	0	0	2.64249261348375	5.793249931424232	ACTA2;COL5A2;ENG
Fetal and neonatal alloimmune thrombocytopenia ORPHA:853	3/105	0.11165484528789996	0.38261341888465084	0	0	2.64249261348375	5.793249931424232	ITGA2;THBS1;NRGN
Herpes simplex virus encephalitis ORPHA:1930	3/105	0.11165484528789996	0.38261341888465084	0	0	2.64249261348375	5.793249931424232	CASP7;TLR6;KCNN4
Osteogenesis imperfecta type 2 ORPHA:216804	3/105	0.11165484528789996	0.38261341888465084	0	0	2.64249261348375	5.793249931424232	COL12A1;COL5A2;SNAI2
Posterior polymorphous corneal dystrophy ORPHA:98973	3/105	0.11165484528789996	0.38261341888465084	0	0	2.64249261348375	5.793249931424232	EHF;LAMA3;PBX1
Familial exudative vitreoretinopathy ORPHA:891	3/106	0.11401789183522644	0.39008983025342975	0	0	2.6167043489825774	5.681911553806121	KITLG;CCND1;AMOTL2
Neuroblastoma ORPHA:635	3/107	0.11639986816238115	0.3969770464111636	0	0	2.591412012644889	5.57341168895459	GABRQ;TMSB15A;TET1
Renal agenesis, unilateral ORPHA:93100	3/107	0.11639986816238115	0.3969770464111636	0	0	2.591412012644889	5.57341168895459	LIFR;AMOTL2;PBX1
Early-onset posterior polar cataract ORPHA:98993	3/108	0.11880049310637775	0.40452319804576725	0	0	2.5666014350945856	5.46765598797467	ADAMTS15;CCND1;AMOTL2
Cleft lip/palate ORPHA:199306	3/109	0.1212194847003795	0.41016404257109546	0	0	2.542258981649005	5.364554027339385	LAMA3;AMOTL2;S100A14
Familial pancreatic carcinoma ORPHA:1333	3/109	0.1212194847003795	0.41016404257109546	0	0	2.542258981649005	5.364554027339385	CENPE;ESCO2;CLSPN
Nephroblastoma ORPHA:654	3/109	0.1212194847003795	0.41016404257109546	0	0	2.542258981649005	5.364554027339385	CENPE;DEPDC1B;CLSPN
Osteogenesis imperfecta type 4 ORPHA:216820	3/109	0.1212194847003795	0.41016404257109546	0	0	2.542258981649005	5.364554027339385	COL12A1;COL5A2;SNAI2
Left ventricular noncompaction ORPHA:54260	3/110	0.12365656021596408	0.4177534028018127	0	0	2.518371527333248	5.264019113408958	SCHIP1;SORBS1;RBM24
Giant cell glioblastoma ORPHA:251579	3/112	0.12858382922909536	0.433039750392822	0	0	2.471911524443886	5.070321192576864	GANAB;CCND1;SMAD6
Gliosarcoma ORPHA:251576	3/112	0.12858382922909536	0.433039750392822	0	0	2.471911524443886	5.070321192576864	GANAB;CCND1;SMAD6
Idiopathic pulmonary fibrosis ORPHA:2032	3/113	0.13107345460727263	0.43936148647173007	0	0	2.4493150684931506	4.977001828263582	GANAB;STN1;ADAM15
Midline interhemispheric variant of holoprosencephaly ORPHA:93926	3/113	0.13107345460727263	0.43936148647173007	0	0	2.4493150684931506	4.977001828263582	FGF19;AMOTL2;GLI2
Septopreoptic holoprosencephaly ORPHA:280195	3/113	0.13107345460727263	0.43936148647173007	0	0	2.4493150684931506	4.977001828263582	FGF19;AMOTL2;GLI2
Semilobar holoprosencephaly ORPHA:220386	3/114	0.13358002787047582	0.4470672161388242	0	0	2.427125755892879	4.885936476037858	TMSB15A;FGF19;GLI2
Male infertility with azoospermia or oligozoospermia due to single gene mutation ORPHA:399805	3/115	0.1361032641627186	0.4548046963946745	0	0	2.4053326810176126	4.7970545129740225	ACBD7;ESCO2;SPC25
Brugada syndrome ORPHA:130	3/122	0.15420854459712316	0.5145066480201691	0	0	2.2630367215379303	4.23063265699741	LIFR;SORBS1;PBX1
Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636	3/172	0.29850145229191377	0.6239678957896782	0	0	1.5894463808057064	1.9216096497704864	LIFR;SORBS1;PBX1
Acrofacial dysostosis, Weyers type ORPHA:952	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	COL5A2;SNAI2
Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form ORPHA:79399	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	KRT13;S100A14
Autosomal dominant generalized epidermolysis bullosa simplex, severe form ORPHA:79396	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	KRT13;S100A14
Autosomal recessive cutis laxa type 1 ORPHA:90349	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	ACTA2;COL5A2
Autosomal recessive distal renal tubular acidosis ORPHA:402041	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	PADI3;S100A14
De novo thrombotic microangiopathy after kidney transplantation ORPHA:244275	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	PLSCR4;TGM2
Epidermolysis bullosa simplex with mottled pigmentation ORPHA:79397	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	KRT13;S100A14
Generalized pseudohypoaldosteronism type 1 ORPHA:171876	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	EHF;S100A14
Hyperandrogenism due to cortisone reductase deficiency ORPHA:168588	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	GPNMB;ENG
KID syndrome ORPHA:477	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	EHF;S100A14
Liddle syndrome ORPHA:526	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	EHF;S100A14
Localized epidermolysis bullosa simplex ORPHA:79400	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	KRT13;S100A14
Ocular albinism with congenital sensorineural deafness ORPHA:352740	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	GPNMB;OSTM1
Pachyonychia congenita ORPHA:2309	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	KRT13;S100A14
Van der Woude syndrome ORPHA:888	2/100	0.30494228683646235	0.6239678957896782	0	0	1.8256029684601114	2.168145862461018	EHF;S100A14
22q11.2 duplication syndrome ORPHA:1727	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SIX2;WNT9A
2q32q33 microdeletion syndrome ORPHA:251019	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	RHOBTB3;SMAD6
2q37 microdeletion syndrome ORPHA:1001	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	MYO15B;DNHD1
3-hydroxy-3-methylglutaric aciduria ORPHA:20	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SLC22A18;ABHD14B
3-phosphoserine phosphatase deficiency, infantile/juvenile form ORPHA:79350	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;OIP5
46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome ORPHA:168563	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CHST1;SNCG
ADULT syndrome ORPHA:978	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KRT13;S100A14
ANGPT1-related hereditary angioedema with normal C1Inh ORPHA:537891	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PLSCR4;VGLL3
ANK3-related intellectual disability-sleep disturbance syndrome ORPHA:356996	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CNTNAP2;PBX1
Aarskog-Scott syndrome ORPHA:915	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	AMOTL2;C1QL1
Achondroplasia ORPHA:15	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;AMOTL2
Acrodermatitis enteropathica ORPHA:37	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SLC22A18;ABHD14B
Acromesomelic dysplasia, Maroteaux type ORPHA:40	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CNTNAP1;COL5A2
Acroosteolysis-keloid-like lesions-premature aging syndrome ORPHA:363665	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACTA2;COL5A2
Acute myeloid leukemia with NPM1 somatic mutations ORPHA:402026	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;NOLC1
Adenylosuccinate lyase deficiency ORPHA:46	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OIP5;TOMM22
Adenylosuccinate synthetase-like 1-related distal myopathy ORPHA:482601	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ADPRHL1;HYAL1
Adrenomyeloneuropathy ORPHA:139399	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;ZBTB45
Adult-onset autosomal dominant leukodystrophy ORPHA:99027	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;CLSPN
Adult-onset distal myopathy due to VCP mutation ORPHA:329478	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;PPP1R14B
Adult-onset dystonia-parkinsonism ORPHA:199351	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	MYO15B;DNHD1
Alkaline ceramidase 3 deficiency ORPHA:502444	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OSTM1;CCSAP
Alpha-dystroglycan-related  limb-girdle muscular dystrophy R16 ORPHA:280333	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;AMOTL2
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome ORPHA:1071	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KRT13;S100A14
Anterior segment developmental anomaly ORPHA:88632	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	FGF19;C1QL1
Apert syndrome ORPHA:87	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PCDH7;PBX1
Aplasia of lacrimal and salivary glands ORPHA:86815	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL5A2;SORBS1
Atrial septal defect-atrioventricular conduction defects syndrome ORPHA:1479	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GLI2;C1QL1
Auditory neuropathy-optic atrophy syndrome ORPHA:542585	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PPP1R14B;MRM1
Autism spectrum disorder due to AUTS2 deficiency ORPHA:352490	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LRIG1;PBX1
Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TLR6;PSMB9
Autosomal dominant Charcot-Marie-Tooth disease type 2C ORPHA:99937	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;CTSD
Autosomal dominant Charcot-Marie-Tooth disease type 2D ORPHA:99938	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TRIB3;E2F7
Autosomal dominant Charcot-Marie-Tooth disease type 2K ORPHA:99944	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;FAM234B
Autosomal dominant Charcot-Marie-Tooth disease type 2M ORPHA:228179	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;MKNK2
Autosomal dominant Charcot-Marie-Tooth disease type 2N ORPHA:228174	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;NOLC1
Autosomal dominant Charcot-Marie-Tooth disease type 2Y ORPHA:435387	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;PPP1R14B
Autosomal dominant adult-onset proximal spinal muscular atrophy ORPHA:209335	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	RHOBTB3;AMOTL2
Autosomal dominant brachyolmia ORPHA:93304	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;CTSD
Autosomal dominant congenital benign spinal muscular atrophy ORPHA:1216	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;CTSD
Autosomal dominant intermediate Charcot-Marie-Tooth disease type B ORPHA:100044	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;MKNK2
Autosomal dominant multiple pterygium syndrome ORPHA:65743	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DNHD1;SYNE3
Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome ORPHA:440354	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL5A2;GLI2
Autosomal dominant popliteal pterygium syndrome ORPHA:1300	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Autosomal dominant spastic ataxia type 1 ORPHA:251282	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DNHD1;CORO1A
Autosomal dominant spastic paraplegia type 13 ORPHA:100994	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;NOLC1
Autosomal dominant spastic paraplegia type 31 ORPHA:101011	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;PBX1
Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ORPHA:101097	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;FAM234B
Autosomal recessive Kenny-Caffey syndrome ORPHA:93324	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZW10;OIP5
Autosomal recessive ataxia due to PEX10 deficiency ORPHA:247815	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PPP1R14B;ZBTB45
Autosomal recessive cerebellar ataxia-psychomotor delay syndrome ORPHA:284271	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EFR3B;GPR137C
Autosomal recessive cerebral atrophy ORPHA:363969	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Autosomal recessive extra-oral halitosis ORPHA:562538	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PLSCR4;PBX1
Autosomal recessive intermediate Charcot-Marie-Tooth disease type A ORPHA:217055	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;FAM234B
Autosomal recessive intermediate Charcot-Marie-Tooth disease type C ORPHA:369867	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL12A1;AMOTL2
Autosomal recessive lower motor neuron disease with childhood onset ORPHA:206580	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL12A1;AMOTL2
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency ORPHA:477857	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SULT1A1;SKAP1
Autosomal recessive spastic paraplegia type 48 ORPHA:306511	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;FRMD8
Autosomal recessive spastic paraplegia type 56 ORPHA:320411	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	HABP4;LRIG1
Autosomal recessive spastic paraplegia type 62 ORPHA:401785	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;ZW10
Autosomal recessive spastic paraplegia type 63 ORPHA:401805	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;NRGN
Autosomal recessive spastic paraplegia type 76 ORPHA:488594	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ADAM15;CTSD
B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:536467	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PPP1R14B;ZBTB45
B4GALT1-CDG ORPHA:79332	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CASP7;ABHD14B
BENTA disease ORPHA:464336	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CORO1A;SKAP1
BNAR syndrome ORPHA:217266	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;SORBS1
Basel-Vanagaite-Smirin-Yosef syndrome ORPHA:464738	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;ZBTB45
Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TSC22D1;TIMP2
Bietti crystalline dystrophy ORPHA:41751	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	P2RX7;KAT2B
Birt-Hogg-Dube syndrome ORPHA:122	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	MYO15B;DNHD1
Blepharophimosis-ptosis-epicanthus inversus syndrome plus ORPHA:572333	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GAL;GLI2
Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 ORPHA:572354	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GAL;GLI2
Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 ORPHA:572361	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GAL;GLI2
Blue rubber bleb nevus ORPHA:1059	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL5A2;PLSCR4
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency ORPHA:91135	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL12A1;AMOTL2
Branchioskeletogenital syndrome ORPHA:1299	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL12A1;COL5A2
Burkitt lymphoma ORPHA:543	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NOLC1;TRIB3
CLN11 disease ORPHA:314629	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SLC22A18;CTSD
Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;AMOTL2
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome ORPHA:436174	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;ZW10
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome ORPHA:504476	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CENPE;CLSPN
Cerebellar ataxia, Cayman type ORPHA:94122	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SLC4A8;EFR3B
Charcot-Marie-Tooth disease type 2H ORPHA:101102	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;FAM234B
Charcot-Marie-Tooth disease type 4A ORPHA:99948	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;FAM234B
Charcot-Marie-Tooth disease type 4B1 ORPHA:99955	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CENPE;E2F7
Charcot-Marie-Tooth disease type 4D ORPHA:99950	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TIMP2;CTSD
Charcot-Marie-Tooth disease type 4H ORPHA:99954	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SORT1;CPEB4
Chondrodysplasia with joint dislocations, gPAPP type ORPHA:280586	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SMIM13;SETD7
Chronic myeloproliferative disease, unclassifiable ORPHA:86830	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACTA2;COL5A2
Citrullinemia type II ORPHA:247585	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;PIR
Clear cell renal carcinoma ORPHA:319276	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SLC22A18;CTSD
Cleidocranial dysplasia ORPHA:1452	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TLR6;PSMB9
Colobomatous microphthalmia-rhizomelic dysplasia syndrome ORPHA:424099	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PBX1;GPR137C
Combined immunodeficiency due to CD27 deficiency ORPHA:238505	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CORO1A;SKAP1
Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZW10;E2F7
Combined immunodeficiency-enteropathy spectrum ORPHA:436252	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KCNN4;CORO1A
Combined oxidative phosphorylation defect type 2 ORPHA:254920	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OIP5;TOMM22
Complex lethal osteochondrodysplasia ORPHA:457378	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KAT2B;CPEB4
Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ARRDC4;RHOU
Congenital contractural arachnodactyly ORPHA:115	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	P3H2;GLI2
Congenital generalized hypercontractile muscle stiffness syndrome ORPHA:476406	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TOMM22;MICB
Congenital limbs-face contractures-hypotonia-developmental delay syndrome ORPHA:562528	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SCHIP1;SCG2
Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NOLC1;TRIB3
Congenital primary aphakia ORPHA:83461	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	FGF19;C1QL1
Congenital tufting enteropathy ORPHA:92050	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PRR15;S100A14
Connective tissue disorder due to lysyl hydroxylase-3 deficiency ORPHA:300284	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;ADAM15
Coralliform cataract ORPHA:98990	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;TMSB15A
Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation ORPHA:300570	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	AMOTL2;C1QL1
Cranio-osteoarthropathy ORPHA:1525	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	IQGAP2;SKAP1
Craniofacial-deafness-hand syndrome ORPHA:1529	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SNAI2;GLI2
Craniofrontonasal dysplasia ORPHA:1520	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ADAMTS15;SNAI2
Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;AMOTL2
Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome ORPHA:1555	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PCDH7;PBX1
DDOST-CDG ORPHA:300536	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;PPP1R14B
DOORS syndrome ORPHA:79500	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	FAM234B;EFR3B
Deafness with labyrinthine aplasia, microtia, and microdontia ORPHA:90024	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;FGF19
Deafness-encephaloneuropathy-obesity-valvulopathy syndrome ORPHA:254898	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OIP5;SHCBP1
Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;KCNN4
Dent disease type 2 ORPHA:93623	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;AMOTL2
Dermatosparaxis Ehlers-Danlos syndrome ORPHA:1901	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACTA2;COL5A2
Diencephalic-mesencephalic junction dysplasia ORPHA:319192	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	MYO15B;ENG
Donnai-Barrow syndrome ORPHA:2143	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CNTNAP2;EFR3B
Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;PIR
Dubin-Johnson syndrome ORPHA:234	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ABCC2;CYP4F2
Dysbetalipoproteinemia ORPHA:412	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GPNMB;SORBS1
EEC syndrome ORPHA:1896	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KRT13;S100A14
Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome ORPHA:496756	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZW10;OIP5
Ectodermal dysplasia-skin fragility syndrome ORPHA:158668	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LAMA3;S100A14
Ectodermal dysplasia-syndactyly syndrome ORPHA:247820	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
External auditory canal aplasia/hypoplasia ORPHA:141074	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KAT2B;SYNE3
FGFR2-related bent bone dysplasia ORPHA:313855	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PCDH7;PBX1
Familial digital arthropathy-brachydactyly ORPHA:85169	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;CTSD
Familial dyskinesia and facial myokymia ORPHA:324588	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CHST1;SORBS1
Familial episodic pain syndrome with predominantly upper body involvement ORPHA:391389	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACTA2;GPNMB
Familial hypocalciuric hypercalcemia type 2 ORPHA:101049	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;AMOTL2
Familial normophosphatemic tumoral calcinosis ORPHA:306658	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TLR6;PSMB9
Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement ORPHA:31043	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Familial scaphocephaly syndrome, McGillivray type ORPHA:168624	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PCDH7;PBX1
Familial spontaneous pneumothorax ORPHA:2903	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	MYO15B;DNHD1
Familial steroid-resistant nephrotic syndrome with adrenal insufficiency ORPHA:506334	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Fetal akinesia-cerebral and retinal hemorrhage syndrome ORPHA:363409	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;MKNK2
Fetal encasement syndrome ORPHA:465824	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZW10;KBTBD8
Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	FAM234B;EFR3B
Fraser syndrome ORPHA:2052	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PCDH7;PBX1
Fucosidosis ORPHA:349	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NEU1;CTSD
Fuhrmann syndrome ORPHA:2854	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZBED2;SUSD4
GM2 gangliosidosis, AB variant ORPHA:309246	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GPNMB;CTSD
Generalized epilepsy-paroxysmal dyskinesia syndrome ORPHA:79137	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL12A1;COL5A2
Gingival fibromatosis-hypertrichosis syndrome ORPHA:2026	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KAT2B;CPEB4
Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome ORPHA:488613	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;FAM219A
Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ALDH3B1;KRT23
Goldmann-Favre syndrome ORPHA:53540	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PBX1;GPR137C
Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TLR6;SYNE3
Hawkinsinuria ORPHA:2118	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ABCC2;HYAL1
Hemolytic anemia due to adenylate kinase deficiency ORPHA:86817	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SNCG;RBM24
Hereditary coproporphyria ORPHA:79273	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZW10;OIP5
Hyper-IgM syndrome type 5 ORPHA:101092	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NOLC1;OIP5
Hyperinsulinism due to INSR deficiency ORPHA:263458	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SORBS1;PBX1
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;OIP5
Hypochondroplasia ORPHA:429	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;AMOTL2
Hypodontia-dysplasia of nails syndrome ORPHA:2228	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	AMOTL2;SMAD6
Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome ORPHA:528105	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KRT23;SORL1
Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism ORPHA:100034	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SIX2;S100A14
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SNCG;SMAD6
Ichthyosis-hypotrichosis syndrome ORPHA:91132	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Idiopathic bronchiectasis ORPHA:60033	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Immunodeficiency with factor H anomaly ORPHA:200421	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PLSCR4;TGM2
Immunodeficiency with factor I anomaly ORPHA:200418	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PLSCR4;TGM2
Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome ORPHA:522077	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GPR37;SCG2
Infantile nephropathic cystinosis ORPHA:411629	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	FRMD8;CTSD
Infantile neuroaxonal dystrophy ORPHA:35069	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	MYO15B;DNHD1
Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACSL5;PSMB9
Insulin-resistance syndrome type A ORPHA:2297	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SORBS1;PBX1
Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome ORPHA:369837	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;ADAM15
Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TSC22D1;TIMP2
Isolated congenital digital clubbing ORPHA:217059	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	IQGAP2;SKAP1
Isolated sulfite oxidase deficiency ORPHA:99731	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	HYAL1;ICA1
Jackson-Weiss syndrome ORPHA:1540	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PCDH7;PBX1
Jalili syndrome ORPHA:1873	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;ADAM15
Juvenile nephropathic cystinosis ORPHA:411634	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	FRMD8;CTSD
Kaposiform hemangioendothelioma ORPHA:2122	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PLSCR4;PBX1
Keipert syndrome ORPHA:2662	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KITLG;AMOTL2
Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency ORPHA:300179	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL12A1;VGLL3
L-2-hydroxyglutaric aciduria ORPHA:79314	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACBD7;SPC25
LAMA5-related multisystemic syndrome ORPHA:521450	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;AMOTL2
Late-onset retinal degeneration ORPHA:67042	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL5A2;PLSCR4
Leprechaunism ORPHA:508	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SORBS1;PBX1
Lethal arteriopathy syndrome due to fibulin-4 deficiency ORPHA:314718	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACTA2;COL5A2
Lethal congenital contracture syndrome type 2 ORPHA:137776	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Lethal osteosclerotic bone dysplasia ORPHA:1832	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	FZD1;TIMP2
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;OIP5
Limb-mammary syndrome ORPHA:69085	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KRT13;S100A14
Lipoprotein glomerulopathy ORPHA:329481	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GPNMB;SORBS1
Lipoyl transferase 2 deficiency ORPHA:447795	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OIP5;MRM1
Lissencephaly due to TUBA1A mutation ORPHA:171680	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;SLC4A8
Lissencephaly syndrome, Norman-Roberts type ORPHA:89844	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;SORBS1
Lissencephaly type 1 due to doublecortin gene mutation ORPHA:2148	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DRAXIN;SLC4A8
Mullerian aplasia and hyperandrogenism ORPHA:247768	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
MAN1B1-CDG ORPHA:397941	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;ADAM15
MIRAGE syndrome ORPHA:494433	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TLR6;PSMB9
MYH9-related disease ORPHA:182050	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TPM4;FRMD8
Marfan syndrome type 2 ORPHA:284973	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACSL5;ENG
Marshall syndrome ORPHA:560	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL5A2;GLI2
McLeod neuroacanthocytosis syndrome ORPHA:59306	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CA2;RGS6
Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TLR6;PSMB9
Metatropic dysplasia ORPHA:2635	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;CTSD
Microcornea-myopic chorioretinal atrophy-telecanthus syndrome ORPHA:369970	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SCHIP1;EFR3B
Microcystic stromal tumor ORPHA:569248	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KITLG;AMOTL2
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome ORPHA:476126	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL12A1;AMOTL2
Microphthalmia with limb anomalies ORPHA:1106	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GPR37;LIFR
Mild hemophilia A ORPHA:169808	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KAT2B;HSDL2
Moderately severe hemophilia A ORPHA:169805	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KAT2B;HSDL2
Mohr-Tranebjaerg syndrome ORPHA:52368	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OIP5;TOMM22
Monosomy 22q13.3 ORPHA:48652	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;AMOTL2
Mucocutaneous venous malformations ORPHA:2451	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL5A2;PLSCR4
Mucolipidosis type III gamma ORPHA:423470	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SLC22A18;CTSD
Mucopolysaccharidosis type 7 ORPHA:584	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SLC22A18;ABHD14B
Muenke syndrome ORPHA:53271	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;AMOTL2
Multiple endocrine neoplasia type 4 ORPHA:276152	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZBTB18;KAT2B
Multiple epiphyseal dysplasia, Al-Gazali type ORPHA:166024	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	AMOTL2;GLI2
Multiple intestinal atresia ORPHA:2300	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KCNN4;CORO1A
Multiple sulfatase deficiency ORPHA:585	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ALDH3B1;SUMF1
Multiple system atrophy, cerebellar type ORPHA:227510	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OIP5;TOMM22
Multiple system atrophy, parkinsonian type ORPHA:98933	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OIP5;TOMM22
Multisystemic smooth muscle dysfunction syndrome ORPHA:404463	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACTA2;COL5A2
Muscle-eye-brain disease with bilateral multicystic leucodystrophy ORPHA:370997	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;AMOTL2
Muscular dystrophy, Selcen type ORPHA:199340	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;AMOTL2
Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NOLC1;OIP5
Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement ORPHA:168947	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACTA2;COL5A2
Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement ORPHA:168950	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACTA2;COL5A2
Myosclerosis ORPHA:289380	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL5A2;TIMP2
NON RARE IN EUROPE: Berger disease ORPHA:34145	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	MYO15B;ENG
NON RARE IN EUROPE: Hemochromatosis type 1 ORPHA:139498	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ALDH3B1;SUMF1
NON RARE IN EUROPE: Isolated keratoconus ORPHA:2335	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PLEKHD1;GPR137C
NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency ORPHA:751	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SLC22A18;CTSD
Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Nail-patella syndrome ORPHA:2614	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DMBX1;C6ORF141
Nail-patella-like renal disease ORPHA:2613	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DMBX1;C6ORF141
Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;PIR
Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;ADAM15
Neurodegenerative syndrome due to cerebral folate transport deficiency ORPHA:217382	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	AMOTL2;S100A14
Neurogenic arthrogryposis multiplex congenita ORPHA:1143	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;ADAM15
Neutrophil immunodeficiency syndrome ORPHA:183707	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CORO1A;PSMB9
Nicolaides-Baraitser syndrome ORPHA:3051	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KAT2B;SYNE3
Niemann-Pick disease type A ORPHA:77292	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CTSD;ENG
Niemann-Pick disease type B ORPHA:77293	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CTSD;ENG
Non-epidermolytic palmoplantar keratoderma ORPHA:2337	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Noonan syndrome-like disorder with juvenile myelomonocytic leukemia ORPHA:363972	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DOCK11;CHST11
OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PLSCR4;AMOTL2
Obesity due to prohormone convertase I deficiency ORPHA:71528	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;SCG2
Ocular cystinosis ORPHA:411641	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	FRMD8;CTSD
Oculoauricular syndrome, Schorderet type ORPHA:157962	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;C1QL1
Oculocerebrorenal syndrome of Lowe ORPHA:534	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;AMOTL2
Oculotrichoanal syndrome ORPHA:2717	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;SORBS1
Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome ORPHA:543470	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PPP1R14B;MRM1
Otodental syndrome ORPHA:2791	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;FGF19
Oxoglutaric aciduria ORPHA:31	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;ADAM15
PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;OIP5
PDE4D haploinsufficiency syndrome ORPHA:439822	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KAT2B;PDE4B
PGM1-CDG ORPHA:319646	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	HSDL2;AMOTL2
Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome ORPHA:85112	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PBX1;GLI2
Parastremmatic dwarfism ORPHA:2646	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;CTSD
Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome ORPHA:444138	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PRSS23;TGM2
Pelizaeus-Merzbacher-like disease due to HSPD1 mutation ORPHA:280288	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;NOLC1
Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease ORPHA:163746	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SORBS1;LZTS1
Persistent polyclonal B-cell lymphocytosis ORPHA:300324	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CORO1A;SKAP1
Peters plus syndrome ORPHA:709	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SMIM13;B3GLCT
Peutz-Jeghers syndrome ORPHA:2869	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;BBC3
Pfeiffer syndrome type 2 ORPHA:93259	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PCDH7;PBX1
Pfeiffer syndrome type 3 ORPHA:93260	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PCDH7;PBX1
Phakomatosis cesiomarmorata ORPHA:79484	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;AMOTL2
Phocomelia, Schinzel type ORPHA:2879	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZBED2;SUSD4
Pilomatrixoma ORPHA:91414	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KITLG;AMOTL2
Polyglucosan body myopathy type 1 ORPHA:397937	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;SLC22A18
Polymicrogyria with optic nerve hypoplasia ORPHA:250972	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	RGS6;NRGN
Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome ORPHA:171848	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;CTSD
Pontocerebellar hypoplasia type 3 ORPHA:97249	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PCDH7;LIFR
Pontocerebellar hypoplasia type 9 ORPHA:369920	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;NRGN
Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome ORPHA:477673	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GPR37;AMOTL2
Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CORO1A;PSMB9
Primary dystonia, DYT4 type ORPHA:98805	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;CA11
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;CLSPN
Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;OIP5
Progressive myoclonic epilepsy with dystonia ORPHA:352596	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	FAM234B;EFR3B
Proteasome-associated autoinflammatory syndrome ORPHA:324977	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACSL5;PSMB9
Pseudohypoaldosteronism type 2D ORPHA:300525	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZBTB18;GRAMD1B
Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa ORPHA:436274	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL12A1;AMOTL2
Pyle disease ORPHA:3005	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACTA2;PLSCR4
Pyridoxal phosphate-responsive seizures ORPHA:79096	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NCEH1;TEKT4P2
Pyruvate dehydrogenase phosphatase deficiency ORPHA:79246	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NCEH1;ENC1
Quebec platelet disorder ORPHA:220436	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	RPSAP52;TPM4
REN-related autosomal dominant tubulointerstitial kidney disease ORPHA:217330	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Rabson-Mendenhall syndrome ORPHA:769	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SORBS1;PBX1
Renal coloboma syndrome ORPHA:1475	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;C1QL1
Reticular dysgenesis ORPHA:33355	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NOLC1;OIP5
Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome ORPHA:494439	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ESCO2;CLSPN
Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	FAM234B;EFR3B
SATB2-associated syndrome due to a chromosomal rearrangement ORPHA:251028	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	RHOBTB3;SMAD6
SATB2-associated syndrome due to a pathogenic variant ORPHA:576283	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	RHOBTB3;SMAD6
SERKAL syndrome ORPHA:139466	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
STT3A-CDG ORPHA:370921	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;ZW10
Sandhoff disease, adult form ORPHA:309169	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NCEH1;NEU1
Sandhoff disease, infantile form ORPHA:309155	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NCEH1;NEU1
Sandhoff disease, juvenile form ORPHA:309162	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	NCEH1;NEU1
Sanfilippo syndrome type A ORPHA:79269	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SLC22A18;CTSD
Sanfilippo syndrome type C ORPHA:79271	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TIMP2;ENG
Sanjad-Sakati syndrome ORPHA:2323	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZW10;OIP5
Scapuloperoneal spinal muscular atrophy ORPHA:431255	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;CTSD
Schimke immuno-osseous dysplasia ORPHA:1830	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;MRM1
Sea-blue histiocytosis ORPHA:158029	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GPNMB;SORBS1
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;AMOTL2
Severe combined immunodeficiency due to CARD11 deficiency ORPHA:357237	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CORO1A;SKAP1
Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;NOLC1
Severe combined immunodeficiency due to LCK deficiency ORPHA:280142	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CORO1A;SKAP1
Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;ADAM15
Severe hemophilia A ORPHA:169802	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KAT2B;HSDL2
Severe hereditary thrombophilia due to congenital protein S deficiency ORPHA:743	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PLSCR4;LIFR
Severe intellectual disability-progressive spastic diplegia syndrome ORPHA:404473	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KITLG;AMOTL2
Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ABHD14B;CTSD
Short rib-polydactyly syndrome, Saldino-Noonan type ORPHA:93270	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PCDH7;LIFR
Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome ORPHA:397623	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TMSB15A;SIX2
Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DEPDC1B;OIP5
Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome ORPHA:477831	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ACTA2;COL5A2
Smith-Lemli-Opitz syndrome ORPHA:818	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;PPP1R14B
Spastic paraplegia-Paget disease of bone syndrome ORPHA:329475	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;PPP1R14B
Spinocerebellar ataxia type 15/16 ORPHA:98769	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	P2RX7;SYNE3
Spinocerebellar ataxia type 21 ORPHA:98773	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CNTNAP1;FAM219A
Spinocerebellar ataxia type 29 ORPHA:208513	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	P2RX7;SYNE3
Spinocerebellar ataxia type 4 ORPHA:98765	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	GANAB;MRM1
Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	E2F7;C1QL1
Spondyloepiphyseal dysplasia, Maroteaux type ORPHA:263482	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;CTSD
Spondylometaphyseal dysplasia, Kozlowski type ORPHA:93314	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;CTSD
Sporadic porphyria cutanea tarda ORPHA:443057	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ALDH3B1;SUMF1
Stickler syndrome type 2 ORPHA:90654	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	COL5A2;GLI2
Symptomatic form of hemochromatosis type 1 ORPHA:465508	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ALDH3B1;SUMF1
Symptomatic form of hemophilia A in female carriers ORPHA:177926	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	KAT2B;HSDL2
Syndromic congenital sodium diarrhea ORPHA:563708	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;S100A14
Syndromic microphthalmia type 5 ORPHA:178364	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CNTNAP2;TMSB15A
Systemic primary carnitine deficiency ORPHA:158	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	EHF;LAMA3
TMEM165-CDG ORPHA:314667	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TPM4;SUMF1
Tall stature-scoliosis-macrodactyly of the great toes syndrome ORPHA:329191	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CNTNAP1;COL5A2
Tangier disease ORPHA:31150	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TIMP2;RGL1
Temple-Baraitser syndrome ORPHA:420561	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SCHIP1;SCG2
Temtamy preaxial brachydactyly syndrome ORPHA:363417	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	TPM4;CHST11
Thanatophoric dysplasia type 1 ORPHA:1860	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;AMOTL2
Thanatophoric dysplasia type 2 ORPHA:93274	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	LIFR;AMOTL2
Transcobalamin deficiency ORPHA:859	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	RGL1;CTSD
Transient infantile hypertriglyceridemia and hepatosteatosis ORPHA:300293	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	HYAL1;SORBS1
Tricho-dento-osseous syndrome ORPHA:3352	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SIX2;S100A14
Tubulinopathy-associated dysgyria ORPHA:467166	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ZCCHC12;SCG2
Tufted angioma ORPHA:1063	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PLSCR4;PBX1
Tyrosinemia type 3 ORPHA:69723	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ABCC2;HYAL1
USP18 deficiency ORPHA:481665	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CASP7;LAMP3
Vein of Galen aneurysmal malformation ORPHA:1053	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;AMOTL2
Very long chain acyl-CoA dehydrogenase deficiency ORPHA:26793	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	ADAM15;CTSD
Waardenburg syndrome type 1 ORPHA:894	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SNAI2;GLI2
Waardenburg syndrome type 3 ORPHA:896	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	SNAI2;GLI2
Wolfram-like syndrome ORPHA:411590	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CCND1;AMOTL2
X-linked central congenital hypothyroidism with late-onset testicular enlargement ORPHA:329235	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CNTNAP2;EFR3B
X-linked cerebral adrenoleukodystrophy ORPHA:139396	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	OGFR;ZBTB45
X-linked intellectual disability, Stocco Dos Santos type ORPHA:85288	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	PLSCR4;SORBS1
X-linked intellectual disability, Van Esch type ORPHA:163976	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CENPE;CLSPN
X-linked reticulate pigmentary disorder ORPHA:85453	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	CENPE;CLSPN
XYLT1-CDG ORPHA:370930	2/101	0.3090340995614179	0.6239678957896782	0	0	1.807070707070707	2.1220497336362687	DOCK11;PDE4B
12q14 microdeletion syndrome ORPHA:94063	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	RPSAP52;E2F7
3M syndrome ORPHA:2616	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	COL5A2;AMOTL2
9q33.3q34.11 microdeletion syndrome ORPHA:495818	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	EFR3B;C1QL1
Agnathia-holoprosencephaly-situs inversus syndrome ORPHA:990	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	COL5A2;GLI2
Alveolar soft tissue sarcoma ORPHA:163699	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	OGFR;ZBTB45
Angiocentric glioma ORPHA:251671	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	DOCK11;CHST11
Atrial standstill ORPHA:1344	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	TMSB15A;RBM24
Autosomal recessive progressive external ophthalmoplegia ORPHA:254886	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	OGFR;ADAM15
Brachydactyly type E ORPHA:93387	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	SNAI2;AMOTL2
Cap myopathy ORPHA:171881	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	TPM4;COL12A1
Caudal regression sequence ORPHA:3027	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	GANAB;PPP1R14B
Cenani-Lenz syndrome ORPHA:3258	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	SCHIP1;LIFR
Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	MYO15B;MKNK2
Congenital communicating hydrocephalus ORPHA:269505	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	TET1;LIFR
Cystic leukoencephalopathy without megalencephaly ORPHA:85136	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	CORO1A;PSMB9
Diffuse panbronchiolitis ORPHA:171700	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	EHF;S100A14
Dubowitz syndrome ORPHA:235	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	ZW10;NOLC1
Duchenne muscular dystrophy ORPHA:98896	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	LIFR;SORBS1
Encephalocraniocutaneous lipomatosis ORPHA:2396	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	TMSB15A;GLI2
Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	ADAM15;S100A14
FRAXE intellectual disability ORPHA:100973	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	SLC4A8;MED12L
Familial avascular necrosis of femoral head ORPHA:86820	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	NGFR;AMOTL2
Freeman-Sheldon syndrome ORPHA:2053	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	CNTNAP1;SCHIP1
Frontometaphyseal dysplasia ORPHA:1826	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	GANAB;TPM4
HELLP syndrome ORPHA:244242	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	PLSCR4;TGM2
Hereditary retinoblastoma ORPHA:357027	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	TMSB15A;TET1
Huntington disease ORPHA:399	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	DOCK11;DNHD1
Hypomyelination with atrophy of basal ganglia and cerebellum ORPHA:139441	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	ZCCHC12;SMIM13
Imerslund-Grasbeck syndrome ORPHA:35858	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	MYO15B;ACSL5
Infantile myofibromatosis ORPHA:2591	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	COL12A1;COL5A2
Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	DEPDC1B;OIP5
Isolated trigonocephaly ORPHA:3366	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	COL5A2;LIFR
Juvenile glaucoma ORPHA:98977	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	ACTA2;GPNMB
Large congenital melanocytic nevus ORPHA:626	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	TRIB3;E2F7
Loeys-Dietz syndrome ORPHA:60030	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	DOCK11;TLR6
Megalencephalic leukoencephalopathy with subcortical cysts ORPHA:2478	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	P2RX7;NCALD
NON RARE IN EUROPE: Idiopathic infantile nystagmus ORPHA:651	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	GPR37;PLK2
Neuroendocrine tumor of stomach ORPHA:100075	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	CENPE;CLSPN
Non-hereditary retinoblastoma ORPHA:357034	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	TMSB15A;TET1
PEHO syndrome ORPHA:2836	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	CNTNAP2;EFR3B
Pachydermoperiostosis ORPHA:2796	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	IL22RA1;S100A14
Progressive myoclonic epilepsy type 5 ORPHA:402082	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	GANAB;AMOTL2
Proteus syndrome ORPHA:744	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	OGFR;MKNK2
Punctate palmoplantar keratoderma type 1 ORPHA:79501	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	COL12A1;COL5A2
Recurrent infection due to specific granule deficiency ORPHA:169142	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	FRAT2;CORO1A
Roussy-Levy syndrome ORPHA:3115	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	TIMP2;ENG
Spondyloepimetaphyseal dysplasia with joint laxity ORPHA:93359	2/102	0.3131211396767948	0.6239678957896782	0	0	1.788909090909091	2.077218867115274	CCND1;AMOTL2
Acquired schizencephaly ORPHA:485275	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	EFR3B;NCALD
Autosomal dominant secondary polycythemia ORPHA:247511	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	HYAL1;PLSCR4
Distal hereditary motor neuropathy type 5 ORPHA:139536	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	GPR37;SCG2
Generalized juvenile polyposis/juvenile polyposis coli ORPHA:329971	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	COL5A2;ENG
Hermansky-Pudlak syndrome without pulmonary fibrosis ORPHA:231512	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	ZW10;MICB
Inherited congenital spastic tetraplegia ORPHA:210141	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	PLSCR4;SORBS1
Isolated Klippel-Feil syndrome ORPHA:2345	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	COL5A2;GLI2
Lujan-Fryns syndrome ORPHA:776	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	GANAB;NOLC1
Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome ORPHA:83473	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	ZBTB18;LZTS1
Myxofibrosarcoma ORPHA:79105	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	GANAB;GLI2
Potocki-Shaffer syndrome ORPHA:52022	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	CNTNAP1;GANAB
Rare isolated myopia ORPHA:98619	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	P3H2;CTSD
Small cell lung cancer ORPHA:70573	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	DEPDC1B;E2F7
Squamous cell carcinoma of salivary glands ORPHA:500481	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	FRAT2;TLR6
Squamous cell carcinoma of the hypopharynx ORPHA:494547	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	FRAT2;TLR6
Squamous cell carcinoma of the larynx ORPHA:494550	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	FRAT2;TLR6
Squamous cell carcinoma of the lip ORPHA:502366	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	FRAT2;TLR6
Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	FRAT2;TLR6
Squamous cell carcinoma of the oral cavity ORPHA:502363	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	FRAT2;TLR6
Squamous cell carcinoma of the oropharynx ORPHA:500478	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	FRAT2;TLR6
Subcortical band heterotopia ORPHA:99796	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	SCHIP1;EFR3B
Thyrotoxic periodic paralysis ORPHA:79102	2/103	0.3172030102202174	0.6239678957896782	0	0	1.7711071107110712	2.0336087389873256	GABRQ;EFR3B
Autosomal dominant Emery-Dreifuss muscular dystrophy ORPHA:98853	2/104	0.32127932362803535	0.6268296504510718	0	0	1.7536541889483066	1.9911767707922197	PRSS23;THBS1
Cerulean cataract ORPHA:98989	2/104	0.32127932362803535	0.6268296504510718	0	0	1.7536541889483066	1.9911767707922197	ZCCHC12;TMSB15A
Congenital muscular dystrophy without intellectual disability ORPHA:370980	2/104	0.32127932362803535	0.6268296504510718	0	0	1.7536541889483066	1.9911767707922197	CNTNAP1;GANAB
Dejerine-Sottas syndrome ORPHA:64748	2/104	0.32127932362803535	0.6268296504510718	0	0	1.7536541889483066	1.9911767707922197	TIMP2;ENG
Epidermodysplasia verruciformis ORPHA:302	2/104	0.32127932362803535	0.6268296504510718	0	0	1.7536541889483066	1.9911767707922197	CORO1A;PSMB9
Hereditary hemorrhagic telangiectasia ORPHA:774	2/104	0.32127932362803535	0.6268296504510718	0	0	1.7536541889483066	1.9911767707922197	ACTA2;ENG
NON RARE IN EUROPE: Alzheimer disease ORPHA:238616	2/104	0.32127932362803535	0.6268296504510718	0	0	1.7536541889483066	1.9911767707922197	MYO15B;SORL1
Silver-Russell syndrome due to a point mutation ORPHA:397590	2/104	0.32127932362803535	0.6268296504510718	0	0	1.7536541889483066	1.9911767707922197	RPSAP52;GLI2
Systemic-onset juvenile idiopathic arthritis ORPHA:85414	2/104	0.32127932362803535	0.6268296504510718	0	0	1.7536541889483066	1.9911767707922197	CTSD;ENG
46,XX testicular disorder of sex development ORPHA:393	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	AMOTL2;GLI2
Congenital fiber-type disproportion myopathy ORPHA:2020	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	ADPRHL1;RBM24
Cystic fibrosis ORPHA:586	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	TSC22D1;ITGA2
Diffuse cutaneous systemic sclerosis ORPHA:220393	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	CCN2;PSMB9
Familial multiple meningioma ORPHA:263662	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	GANAB;PDGFB
Fetal akinesia deformation sequence ORPHA:994	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	ADPRHL1;RBM24
Hereditary hyperekplexia ORPHA:3197	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	SCHIP1;LIFR
Hypothyroidism due to deficient transcription factors involved in pituitary development or function ORPHA:226307	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	SCML2;CLSPN
Multiple endocrine neoplasia type 1 ORPHA:652	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	ADAM15;BBC3
Primary hypereosinophilic syndrome ORPHA:314950	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	ACTA2;COL5A2
Skeletal Ewing sarcoma ORPHA:319	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	TPM4;COL5A2
Stargardt disease ORPHA:827	2/105	0.3253497014569191	0.6279395134845649	0	0	1.736540158870256	1.949882228154365	LIFR;PBX1
Adams-Oliver syndrome ORPHA:974	2/106	0.3294137742811992	0.6340773186521831	0	0	1.7197552447552447	1.9096861246679653	RGL1;ENG
Limited cutaneous systemic sclerosis ORPHA:220402	2/106	0.3294137742811992	0.6340773186521831	0	0	1.7197552447552447	1.9096861246679653	CCN2;PSMB9
NON RARE IN EUROPE: Primary adult open-angle glaucoma ORPHA:353225	2/106	0.3294137742811992	0.6340773186521831	0	0	1.7197552447552447	1.9096861246679653	COL12A1;RBM24
Aicardi-Goutieres syndrome ORPHA:51	2/107	0.33347118154958744	0.639029370164481	0	0	1.7032900432900433	1.8705511318492734	CORO1A;PSMB9
Hereditary clear cell renal cell carcinoma ORPHA:422526	2/107	0.33347118154958744	0.639029370164481	0	0	1.7032900432900433	1.8705511318492734	P2RX7;FHIT
Hypotrichosis simplex ORPHA:55654	2/107	0.33347118154958744	0.639029370164481	0	0	1.7032900432900433	1.8705511318492734	EHF;S100A14
Periventricular nodular heterotopia ORPHA:98892	2/107	0.33347118154958744	0.639029370164481	0	0	1.7032900432900433	1.8705511318492734	CCND1;AMOTL2
Semantic dementia ORPHA:100069	2/107	0.33347118154958744	0.639029370164481	0	0	1.7032900432900433	1.8705511318492734	GPNMB;CTSD
Narcolepsy type 1 ORPHA:2073	2/108	0.3375215713931006	0.64564126367818	0	0	1.6871355060034305	1.8324414947572332	P2RX7;CORO1A
Primary biliary cholangitis ORPHA:186	2/108	0.3375215713931006	0.64564126367818	0	0	1.6871355060034305	1.8324414947572332	CORO1A;PSMB9
46,XX gonadal dysgenesis ORPHA:243	2/109	0.34156460052263654	0.6522156347158065	0	0	1.6712829226847918	1.7953229521955667	CLSPN;E2F7
Behavioral variant of frontotemporal dementia ORPHA:275864	2/109	0.34156460052263654	0.6522156347158065	0	0	1.6712829226847918	1.7953229521955667	NEU1;CTSD
46,XY complete gonadal dysgenesis ORPHA:242	2/110	0.34559993401304695	0.6581690778726346	0	0	1.6557239057239057	1.7591626621926673	DEPDC1B;E2F7
B-cell chronic lymphocytic leukemia ORPHA:67038	2/110	0.34559993401304695	0.6581690778726346	0	0	1.6557239057239057	1.7591626621926673	P2RX7;CCND1
Meningioma ORPHA:2495	2/110	0.34559993401304695	0.6581690778726346	0	0	1.6557239057239057	1.7591626621926673	GANAB;PDGFB
46,XY partial gonadal dysgenesis ORPHA:251510	2/111	0.349627245303959	0.665250072408594	0	0	1.6404503753127606	1.7239291308099878	SCML2;TET1
Oligodontia ORPHA:99798	2/112	0.353646215851474	0.6723027000992685	0	0	1.6254545454545455	1.6895921467358728	AMOTL2;S100A14
Alobar holoprosencephaly ORPHA:93925	2/113	0.3576565352223945	0.6787273931204523	0	0	1.6107289107289107	1.6561227175916917	FGF19;GLI2
Lobar holoprosencephaly ORPHA:93924	2/113	0.3576565352223945	0.6787273931204523	0	0	1.6107289107289107	1.6561227175916917	AMOTL2;GLI2
Microform holoprosencephaly ORPHA:280200	2/114	0.36165790069355724	0.6857161253678724	0	0	1.5962662337662337	1.6234930121272464	AMOTL2;GLI2
Total early-onset cataract ORPHA:98994	2/116	0.36963259802974646	0.7002194990845196	0	0	1.5681020733652313	1.5606469161975822	GANAB;AMOTL2
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy ORPHA:155	2/117	0.37360536263644456	0.7068064785325423	0	0	1.5543873517786562	1.53038017919701	ADPRHL1;RBM24
Precursor B-cell acute lymphoblastic leukemia ORPHA:99860	2/121	0.3893929174970684	0.7068064785325423	0	0	1.50183346065699	1.4164788201234944	CORO1A;PBX1
Autosomal dominant non-syndromic intellectual disability ORPHA:178469	2/133	0.4356332182075325	0.7068064785325423	0	0	1.3634281748785566	1.1329469577503135	EFR3B;MED12L
Familial isolated dilated cardiomyopathy ORPHA:154	2/135	0.44315890436430344	0.7068064785325423	0	0	1.3427887901572113	1.0927976017339414	ADPRHL1;RBM24
Primary ciliary dyskinesia ORPHA:244	2/136	0.44690101178721114	0.7068064785325423	0	0	1.3327001356852104	1.073380889826263	SPAG1;IQCG
Autosomal recessive multiple pterygium syndrome ORPHA:2990	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	DNHD1
Bifunctional enzyme deficiency ORPHA:300	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	HSDL2
Charcot-Marie-Tooth disease type 2B2 ORPHA:101101	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	OGFR
Deafness-infertility syndrome ORPHA:94064	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	PLEKHD1
Immunodeficiency by defective expression of MHC class I ORPHA:34592	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	PSMB9
Immunodeficiency due to a classical component pathway complement deficiency ORPHA:169147	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	GPNMB
Isolated Dandy-Walker malformation with hydrocephalus ORPHA:269212	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	EFR3B
Isolated Dandy-Walker malformation without hydrocephalus ORPHA:269215	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	EFR3B
Metachromatic leukodystrophy, adult form ORPHA:309271	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	CTSD
Metachromatic leukodystrophy, juvenile form ORPHA:309263	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	CTSD
Metachromatic leukodystrophy, late infantile form ORPHA:309256	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	CTSD
Mitochondrial trifunctional protein deficiency ORPHA:746	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	HSDL2
Pitt-Hopkins-like syndrome ORPHA:221150	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	CNTNAP2
Singleton-Merten dysplasia ORPHA:85191	1/100	0.6733908646234461	0.7068064785325423	0	0	0.8994469582704877	0.3556677156302322	PSMB9
12p12.1 microdeletion syndrome ORPHA:313884	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
14q11.2 microduplication syndrome ORPHA:261229	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
17q21.31 microdeletion syndrome ORPHA:363958	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DNHD1
17q23.1q23.2 microdeletion syndrome ORPHA:261279	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	VGLL3
1p21.3 microdeletion syndrome ORPHA:293948	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
1q44 microdeletion syndrome ORPHA:238769	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
3-methylglutaconic aciduria type 1 ORPHA:67046	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	HSDL2
46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency ORPHA:168558	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
5q14.3 microdeletion syndrome ORPHA:228384	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	P2RX7
6q16 microdeletion syndrome ORPHA:171829	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	VGLL3
7q31 microdeletion syndrome ORPHA:251061	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PCDH7
8p11.2 deletion syndrome ORPHA:251066	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	RGS6
8p23.1 microdeletion syndrome ORPHA:251071	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SMAD6
AICA-ribosiduria ORPHA:250977	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
ALDH18A1-related De Barsy syndrome ORPHA:35664	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
ALG1-CDG ORPHA:79327	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MRM1
ALG8-CDG ORPHA:79325	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OIP5
ALG9-CDG ORPHA:79328	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR137C
ALK-positive anaplastic large cell lymphoma ORPHA:300895	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC4A8
ALK-positive large B-cell lymphoma ORPHA:364043	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC4A8
ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
AXIN2-related attenuated familial adenomatous polyposis ORPHA:401911	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LRIG1
Achondrogenesis type 1B ORPHA:93298	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ITGA2
Achondrogenesis type 2 ORPHA:93296	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Acquired partial lipodystrophy ORPHA:79087	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Acro-renal-ocular syndrome ORPHA:959	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FGF19
Acrocapitofemoral dysplasia ORPHA:63446	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	IL22RA1
Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome ORPHA:466794	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Acute intermittent porphyria ORPHA:79276	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OIP5
Acyl-CoA dehydrogenase 9 deficiency ORPHA:99901	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADAM15
Adult-onset autosomal recessive sideroblastic anemia ORPHA:255132	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Albers Schonberg osteopetrosis ORPHA:53	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Alkaptonuria ORPHA:56	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CYP4F2
Alpers-Huttenlocher syndrome ORPHA:726	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Alpha-mannosidosis, adult form ORPHA:309288	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Alpha-mannosidosis, infantile form ORPHA:309282	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Alpha-sarcoglycan-related  limb-girdle muscular dystrophy R3 ORPHA:62	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Amish lethal microcephaly ORPHA:99742	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MICB
Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Anoctamin-5-related  limb-girdle muscular dystrophy R12 ORPHA:206549	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Anonychia congenita totalis ORPHA:94150	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GABRQ
Anterior maxillary protrusion-strabismus-intellectual disability syndrome ORPHA:562559	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CHST1
Argininosuccinic aciduria ORPHA:23	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC22A18
Arthrogryposis-anterior horn cell disease syndrome ORPHA:53696	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
Ataxia-hypogonadism-choroidal dystrophy syndrome ORPHA:1180	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Ataxia-oculomotor apraxia type 1 ORPHA:1168	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Ataxia-oculomotor apraxia type 4 ORPHA:459033	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Ataxia-pancytopenia syndrome ORPHA:2585	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Atelosteogenesis type II ORPHA:56304	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ITGA2
Atrophoderma vermiculata ORPHA:79100	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TIMP2
Atypical Gaucher disease due to saposin C deficiency ORPHA:309252	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Atypical Werner syndrome ORPHA:79474	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Atypical dentin dysplasia due to SMOC2 deficiency ORPHA:314721	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Autoimmune interstitial lung disease-arthritis syndrome ORPHA:444092	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation ORPHA:487814	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	KRT23
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation ORPHA:324611	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons ORPHA:401964	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DNHD1
Autosomal dominant Charcot-Marie-Tooth disease type 2A1 ORPHA:99946	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Autosomal dominant Charcot-Marie-Tooth disease type 2A2 ORPHA:99947	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Autosomal dominant Charcot-Marie-Tooth disease type 2B ORPHA:99936	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ARL2BP
Autosomal dominant Charcot-Marie-Tooth disease type 2DD ORPHA:521414	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Autosomal dominant Charcot-Marie-Tooth disease type 2E ORPHA:99939	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Autosomal dominant Charcot-Marie-Tooth disease type 2I ORPHA:99942	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Autosomal dominant Charcot-Marie-Tooth disease type 2J ORPHA:99943	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Autosomal dominant Charcot-Marie-Tooth disease type 2U ORPHA:397735	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TRIB3
Autosomal dominant Kenny-Caffey syndrome ORPHA:93325	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Autosomal dominant dopa-responsive dystonia ORPHA:98808	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SKAP1
Autosomal dominant focal dystonia, DYT25 type ORPHA:329466	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CNTNAP2
Autosomal dominant hyper-IgE syndrome ORPHA:2314	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Autosomal dominant hypophosphatemic rickets ORPHA:89937	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCALD
Autosomal dominant intermediate Charcot-Marie-Tooth disease type C ORPHA:100045	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Autosomal dominant intermediate Charcot-Marie-Tooth disease type D ORPHA:100046	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain ORPHA:324585	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Autosomal dominant keratitis ORPHA:2334	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Autosomal dominant neovascular inflammatory vitreoretinopathy ORPHA:329211	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
Autosomal dominant omodysplasia ORPHA:93328	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Autosomal dominant primary microcephaly ORPHA:2514	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Autosomal dominant rhegmatogenous retinal detachment ORPHA:209867	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Autosomal dominant spastic paraplegia type 10 ORPHA:100991	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Autosomal dominant spastic paraplegia type 12 ORPHA:100993	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FAM219A
Autosomal dominant spastic paraplegia type 3 ORPHA:100984	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SCG2
Autosomal dominant spastic paraplegia type 6 ORPHA:100988	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SMIM13
Autosomal dominant spastic paraplegia type 73 ORPHA:444099	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Autosomal dominant spastic paraplegia type 9A ORPHA:447753	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Autosomal dominant spastic paraplegia type 9B ORPHA:447757	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Autosomal dominant spondylocostal dysostosis ORPHA:1797	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ALKBH6
Autosomal dominant striatal neurodegeneration ORPHA:228169	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
Autosomal dominant vitreoretinochoroidopathy ORPHA:3086	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	P2RX7
Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Autosomal recessive ataxia, Beauce type ORPHA:88644	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	KAT2B
Autosomal recessive axonal neuropathy with neuromyotonia ORPHA:324442	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Autosomal recessive bestrophinopathy ORPHA:139455	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	P2RX7
Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency ORPHA:453521	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MICB
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency ORPHA:284282	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MED12L
Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency ORPHA:363432	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CNTNAP2
Autosomal recessive cutis laxa type 2B ORPHA:357064	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Autosomal recessive dopa-responsive dystonia ORPHA:101150	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
Autosomal recessive epidermolytic ichthyosis ORPHA:512103	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Autosomal recessive generalized epidermolysis bullosa simplex ORPHA:89838	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
Autosomal recessive intermediate Charcot-Marie-Tooth disease type B ORPHA:254334	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Autosomal recessive myogenic arthrogryposis multiplex congenita ORPHA:319332	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	KAT2B
Autosomal recessive optic atrophy, OPA7 type ORPHA:227976	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Autosomal recessive proximal renal tubular acidosis ORPHA:93607	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PLSCR4
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency ORPHA:331176	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency ORPHA:423384	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Autosomal recessive spastic ataxia with leukoencephalopathy ORPHA:314603	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Autosomal recessive spastic paraplegia type 15 ORPHA:100996	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DNHD1
Autosomal recessive spastic paraplegia type 18 ORPHA:209951	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Autosomal recessive spastic paraplegia type 26 ORPHA:101006	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
Autosomal recessive spastic paraplegia type 39 ORPHA:139480	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Autosomal recessive spastic paraplegia type 44 ORPHA:320401	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FAM219A
Autosomal recessive spastic paraplegia type 70 ORPHA:401835	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TRIB3
Autosomal recessive spastic paraplegia type 78 ORPHA:513436	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Autosomal recessive spastic paraplegia type 9B ORPHA:447760	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Autosomal spastic paraplegia type 30 ORPHA:101010	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Benign Samaritan congenital myopathy ORPHA:324581	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CA11
Benign paroxysmal torticollis of infancy ORPHA:71518	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC4A8
Best vitelliform macular dystrophy ORPHA:1243	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	P2RX7
Beta-ketothiolase deficiency ORPHA:134	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	HSDL2
Bilateral parasagittal parieto-occipital polymicrogyria ORPHA:208441	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DOCK11
Biotinidase deficiency ORPHA:79241	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NEU1
Birdshot chorioretinopathy ORPHA:179	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Bjornstad syndrome ORPHA:123	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MRM1
Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Blomstrand lethal chondrodysplasia ORPHA:50945	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
Borjeson-Forssman-Lehmann syndrome ORPHA:127	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CENPE
Bowen-Conradi syndrome ORPHA:1270	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Brachydactyly type B2 ORPHA:140908	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYBL1
Brachydactyly-syndactyly, Zhao type ORPHA:93409	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ISL1
Brachytelephalangic chondrodysplasia punctata ORPHA:79345	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PLSCR4
Brain calcification, Rajab type ORPHA:178506	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Brain dopamine-serotonin vesicular transport disease ORPHA:352649	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	IQGAP2
Brody myopathy ORPHA:53347	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OIP5
C syndrome ORPHA:1308	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SKAP1
C11ORF73-related autosomal recessive hypomyelinating leukodystrophy ORPHA:495844	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
CDKL5-related epileptic encephalopathy ORPHA:505652	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR137C
CIDEC-related familial partial lipodystrophy ORPHA:435651	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	IL22RA1
CLCN4-related X-linked intellectual disability syndrome ORPHA:485350	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORT1
CLN13 disease ORPHA:352709	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ENG
CLN2 disease ORPHA:228349	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ENG
CLN3 disease ORPHA:228346	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC22A18
CLN4B disease ORPHA:228343	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
CLN8 disease ORPHA:228354	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DRAXIN
COG4-CDG ORPHA:263501	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
COG8-CDG ORPHA:95428	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TFAP4
Carney complex ORPHA:1359	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TRAK2
Carnitine-acylcarnitine translocase deficiency ORPHA:159	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ABHD14B
Central core disease ORPHA:597	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CA11
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome ORPHA:1171	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Cerebrocostomandibular syndrome ORPHA:1393	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Cerebrotendinous xanthomatosis ORPHA:909	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Cernunnos-XLF deficiency ORPHA:169079	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Charcot-Marie-Tooth disease type 1B ORPHA:101082	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Charcot-Marie-Tooth disease type 1C ORPHA:101083	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Charcot-Marie-Tooth disease type 1D ORPHA:101084	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NR4A2
Charcot-Marie-Tooth disease type 1F ORPHA:101085	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Charcot-Marie-Tooth disease type 2B1 ORPHA:98856	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Charcot-Marie-Tooth disease type 2B5 ORPHA:228374	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Charcot-Marie-Tooth disease type 2P ORPHA:300319	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Charcot-Marie-Tooth disease type 2S ORPHA:443073	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Charcot-Marie-Tooth disease type 4E ORPHA:99951	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NR4A2
Charcot-Marie-Tooth disease type 4J ORPHA:139515	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DOCK11
Cherubism ORPHA:184	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYO15B
Childhood apraxia of speech ORPHA:209908	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PCDH7
Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia ORPHA:284324	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ENG
Childhood-onset basal ganglia degeneration syndrome ORPHA:497906	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Childhood-onset spasticity with hyperglycinemia ORPHA:401866	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Cholesteryl ester storage disease ORPHA:75234	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Chuvash erythrocytosis ORPHA:238557	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TFAP4
Chylomicron retention disease ORPHA:71	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CPEB4
Class I glucose-6-phosphate dehydrogenase deficiency ORPHA:466026	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Classic Bartter syndrome ORPHA:93605	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GLI2
Classic glucose transporter type 1 deficiency syndrome ORPHA:71277	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	E2F7
Classic progressive supranuclear palsy syndrome ORPHA:240071	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Classical-like Ehlers-Danlos syndrome type 1 ORPHA:230839	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Classical-like Ehlers-Danlos syndrome type 2 ORPHA:536532	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	COL5A2
Coffin-Lowry syndrome ORPHA:192	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACSL5
Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome ORPHA:435930	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Combined immunodeficiency due to IL21R deficiency ORPHA:357329	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Combined immunodeficiency due to MALT1 deficiency ORPHA:397964	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR15
Combined immunodeficiency due to ORAI1 deficiency ORPHA:317428	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FRMD8
Combined immunodeficiency due to OX40 deficiency ORPHA:431149	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Combined immunodeficiency due to TFRC deficiency ORPHA:476113	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SHCBP1
Combined immunodeficiency due to ZAP70 deficiency ORPHA:911	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Combined malonic and methylmalonic acidemia ORPHA:289504	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DNHD1
Combined oxidative phosphorylation defect type 13 ORPHA:319514	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ESCO2
Combined oxidative phosphorylation defect type 24 ORPHA:444458	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OIP5
Combined oxidative phosphorylation defect type 25 ORPHA:447954	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Combined oxidative phosphorylation defect type 27 ORPHA:477774	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Combined oxidative phosphorylation defect type 30 ORPHA:478042	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Combined oxidative phosphorylation defect type 39 ORPHA:565624	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
Complete cryptophthalmia ORPHA:98949	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PBX1
Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency ORPHA:90791	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Congenital alpha2-antiplasmin deficiency ORPHA:79	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	HYAL1
Congenital atransferrinemia ORPHA:1195	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Congenital bile acid synthesis defect type 4 ORPHA:79095	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	HSDL2
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome ORPHA:330054	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome ORPHA:521432	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PIR
Congenital cataracts-facial dysmorphism-neuropathy syndrome ORPHA:48431	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Congenital cornea plana ORPHA:53691	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Congenital dyserythropoietic anemia type IV ORPHA:293825	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FRAT2
Congenital factor V deficiency ORPHA:326	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORL1
Congenital factor X deficiency ORPHA:328	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	COL5A2
Congenital factor XII deficiency ORPHA:330	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TRIB3
Congenital hereditary endothelial dystrophy type II ORPHA:293603	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Congenital hereditary facial paralysis-variable hearing loss syndrome ORPHA:306530	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FGF19
Congenital intrauterine infection-like syndrome ORPHA:1229	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
Congenital lactase deficiency ORPHA:53690	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ESCO2
Congenital lethal myopathy, Compton-North type ORPHA:210163	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PCDH7
Congenital multicore myopathy with external ophthalmoplegia ORPHA:98905	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CA11
Congenital muscular dystrophy due to LMNA mutation ORPHA:157973	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Congenital muscular dystrophy with integrin alpha-7 deficiency ORPHA:34520	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Congenital myopathy with excess of thin filaments ORPHA:98904	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADPRHL1
Congenital myopathy with myasthenic-like onset ORPHA:424107	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CA11
Congenital sialidosis type 2 ORPHA:93400	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NEU1
Congenital stromal corneal dystrophy ORPHA:101068	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Corneal dystrophy-perceptive deafness syndrome ORPHA:1490	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Corpus callosum agenesis-abnormal genitalia syndrome ORPHA:2508	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Cortical dysplasia-focal epilepsy syndrome ORPHA:163681	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CNTNAP2
Costello syndrome ORPHA:3071	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Coxopodopatellar syndrome ORPHA:1509	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	VGLL3
Craniosynostosis-dental anomalies ORPHA:284149	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYO15B
Craniosynostosis-microretrognathia-severe intellectual disability syndrome ORPHA:565858	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SETD7
Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TLR6
Cutis marmorata telangiectatica congenita ORPHA:1556	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OIP5
Cystinuria type B ORPHA:93613	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CYP4F2
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TLR6
D,L-2-hydroxyglutaric aciduria ORPHA:356978	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
D-glyceric aciduria ORPHA:941	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC22A18
DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FAM219A
DOCK2 deficiency ORPHA:447737	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
DPAGT1-CDG ORPHA:86309	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Delta-sarcoglycan-related  limb-girdle muscular dystrophy R6 ORPHA:219	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Dermatopathia pigmentosa reticularis ORPHA:86920	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
Desminopathy ORPHA:98909	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Desmoplastic/nodular medulloblastoma ORPHA:251863	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Desmosterolosis ORPHA:35107	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
Developmental and speech delay due to SOX5 deficiency ORPHA:313892	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency ORPHA:289307	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Diastrophic dwarfism ORPHA:628	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ITGA2
Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome ORPHA:404437	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Dihydropyrimidine dehydrogenase deficiency ORPHA:1675	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Distal 22q11.2 microdeletion syndrome ORPHA:261330	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCSAP
Distal anoctaminopathy ORPHA:399096	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Distal arthrogryposis type 5D ORPHA:329457	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Distal hereditary motor neuropathy, Jerash type ORPHA:139552	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Distal monosomy 1q ORPHA:36367	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB18
Distal myopathy, Tateyama type ORPHA:488650	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADPRHL1
Drug- or toxin-induced pulmonary arterial hypertension ORPHA:275786	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
Dyschromatosis universalis hereditaria ORPHA:241	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PIR
Dysspondyloenchondromatosis ORPHA:85198	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Dystonia-parkinsonism-hypermanganesemia syndrome ORPHA:521406	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
EEM syndrome ORPHA:1897	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
EVEN-plus syndrome ORPHA:496751	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome ORPHA:411986	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	RHOBTB3
Early-onset parkinsonism-intellectual disability syndrome ORPHA:2379	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MED12L
East Texas bleeding disorder ORPHA:391320	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORL1
Eiken syndrome ORPHA:79106	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
Encephalopathy due to prosaposin deficiency ORPHA:139406	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Endosteal sclerosis-cerebellar hypoplasia syndrome ORPHA:85186	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
Epidermolysis bullosa simplex due to exophilin 5 deficiency ORPHA:412189	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EHF
Epidermolysis bullosa simplex with muscular dystrophy ORPHA:257	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADAM15
Episodic ataxia type 5 ORPHA:211067	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR137C
Episodic ataxia type 6 ORPHA:209967	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	RGL1
Erythrocyte galactose epimerase deficiency ORPHA:308473	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Estrogen resistance syndrome ORPHA:785	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	KAT2B
Ethylmalonic encephalopathy ORPHA:51188	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ABHD14B
Exercise-induced hyperinsulinism ORPHA:165991	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Exercise-induced malignant hyperthermia ORPHA:466650	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CA11
F12-related hereditary angioedema with normal C1Inh ORPHA:100054	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TRIB3
FADD-related immunodeficiency ORPHA:306550	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
FASTKD2-related infantile mitochondrial encephalomyopathy ORPHA:166105	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
FLNA-related X-linked myxomatous valvular dysplasia ORPHA:555877	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
FOXG1 syndrome ORPHA:561854	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
FOXG1 syndrome due to 14q12 microdeletion ORPHA:261144	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
FTH1-related iron overload ORPHA:247790	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome ORPHA:352712	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CLSPN
Familial Alzheimer-like prion disease ORPHA:280397	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCEH1
Familial GPIHBP1 deficiency ORPHA:535458	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Familial aortic dissection ORPHA:229	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Familial atrial myxoma ORPHA:615	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TRAK2
Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease ORPHA:436242	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Familial benign flecked retina ORPHA:363989	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Familial clubfoot due to 17q23.1q23.2 microduplication ORPHA:238578	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	VGLL3
Familial clubfoot due to 5q31 microdeletion ORPHA:293144	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SIX2
Familial clubfoot due to PITX1 point mutation ORPHA:293150	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SIX2
Familial congenital nasolacrimal duct obstruction ORPHA:451612	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
Familial cortical myoclonus ORPHA:319189	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Familial hypocalciuric hypercalcemia type 3 ORPHA:101050	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Familial lambdoid synostosis ORPHA:3267	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Familial lipoprotein lipase deficiency ORPHA:309015	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Familial male-limited precocious puberty ORPHA:3000	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Familial osteochondritis dissecans ORPHA:251262	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LZTS1
Familial paroxysmal ataxia ORPHA:97	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC4A8
Familial partial lipodystrophy, Dunnigan type ORPHA:2348	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Familial partial lipodystrophy, Kobberling type ORPHA:79084	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement ORPHA:2196	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DRAXIN
Familial pseudohyperkalemia ORPHA:90044	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PIR
Familial sick sinus syndrome ORPHA:166282	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	RBM24
Fatal familial insomnia ORPHA:466	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCEH1
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 ORPHA:168566	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Fatal post-viral neurodegenerative disorder ORPHA:391343	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SKAP1
Feingold syndrome type 1 ORPHA:391641	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Focal dermal hypoplasia ORPHA:2092	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Focal facial dermal dysplasia type IV ORPHA:398189	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DRAXIN
Foveal hypoplasia-presenile cataract syndrome ORPHA:2253	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Friedreich ataxia ORPHA:95	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Frontorhiny ORPHA:391474	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Fryns syndrome ORPHA:2059	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
GM1 gangliosidosis type 1 ORPHA:79255	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NEU1
GM1 gangliosidosis type 2 ORPHA:79256	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NEU1
GM1 gangliosidosis type 3 ORPHA:79257	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NEU1
GNB5-related intellectual disability-cardiac arrhythmia syndrome ORPHA:542306	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR137C
GRACILE syndrome ORPHA:53693	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MRM1
GTP cyclohydrolase I deficiency ORPHA:2102	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SKAP1
Gamma-aminobutyric acid transaminase deficiency ORPHA:2066	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CNTNAP2
Gamma-glutamyl transpeptidase deficiency ORPHA:33573	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC22A18
Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5 ORPHA:353	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	RBM24
Generalized galactose epimerase deficiency ORPHA:308487	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Genetic hyperferritinemia without iron overload ORPHA:254704	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Gerstmann-Straussler-Scheinker syndrome ORPHA:356	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCEH1
Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome ORPHA:480898	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Glutaryl-CoA dehydrogenase deficiency ORPHA:25	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MRM1
Glycogen storage disease due to LAMP-2 deficiency ORPHA:34587	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OSTM1
Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib ORPHA:79259	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Glycogen storage disease due to muscle phosphofructokinase deficiency ORPHA:371	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
Gnathodiaphyseal dysplasia ORPHA:53697	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Gorlin-Chaudhry-Moss syndrome ORPHA:2095	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TPM4
Grange syndrome ORPHA:79094	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Gray platelet syndrome ORPHA:721	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MKNK2
Griscelli syndrome type 1 ORPHA:79476	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC4A8
Griscelli syndrome type 2 ORPHA:79477	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome ORPHA:391348	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Growth delay-intellectual disability-hepatopathy syndrome ORPHA:541423	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Guttmacher syndrome ORPHA:2957	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SMAD6
Hand-foot-genital syndrome ORPHA:2438	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SMAD6
Heart-hand syndrome, Slovenian type ORPHA:168796	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Heme oxygenase-1 deficiency ORPHA:562509	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Hemochromatosis type 5 ORPHA:447792	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	THBS1
Hemolytic anemia due to diphosphoglycerate mutase deficiency ORPHA:714	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ARL2BP
Hemolytic anemia due to glutathione reductase deficiency ORPHA:90030	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OIP5
Hemolytic anemia due to red cell pyruvate kinase deficiency ORPHA:766	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CYP4F2
Hepatic veno-occlusive disease-immunodeficiency syndrome ORPHA:79124	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Hereditary North American Indian childhood cirrhosis ORPHA:168583	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	E2F7
Hereditary fructose intolerance ORPHA:469	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CYP4F2
Hereditary hypercarotenemia and vitamin A deficiency ORPHA:199285	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PRR15
Hereditary hyperferritinemia-cataract syndrome ORPHA:163	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Hereditary motor and sensory neuropathy type 5 ORPHA:64751	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Hereditary orotic aciduria ORPHA:30	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DEPDC1B
Hereditary pediatric Behcet-like disease ORPHA:476102	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Hereditary sensorimotor neuropathy with hyperelastic skin ORPHA:280598	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Hereditary sensory and autonomic neuropathy type 8 ORPHA:478664	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Hereditary thrombocytopenia with early-onset myelofibrosis ORPHA:480851	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Hermansky-Pudlak syndrome type 7 ORPHA:231531	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Hermansky-Pudlak syndrome type 8 ORPHA:231537	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FRMD8
Hirschsprung disease-ganglioneuroblastoma syndrome ORPHA:2151	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ISL1
Holt-Oram syndrome ORPHA:392	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYO15B
Huntington disease-like 1 ORPHA:157941	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCEH1
Huntington disease-like 2 ORPHA:98934	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Hurler syndrome ORPHA:93473	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Hurler-Scheie syndrome ORPHA:93476	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Hyaluronidase deficiency ORPHA:67041	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	HYAL1
Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome ORPHA:528091	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Hyper-IgM syndrome type 3 ORPHA:101090	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Hyperammonemia due to N-acetylglutamate synthase deficiency ORPHA:927	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC22A18
Hyperbiliverdinemia ORPHA:276405	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ARL2BP
Hyperekplexia-epilepsy syndrome ORPHA:163985	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC4A8
Hyperinsulinism due to UCP2 deficiency ORPHA:276556	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Hyperlysinemia ORPHA:2203	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
Hyperprolinemia type 1 ORPHA:419	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CNTNAP2
Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome ORPHA:363694	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MRM1
Hyperzincemia and hypercalprotectinemia ORPHA:251523	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Hypochondrogenesis ORPHA:93297	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Hypomyelination-congenital cataract syndrome ORPHA:85163	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	VGLL3
Hypoparathyroidism-sensorineural deafness-renal disease syndrome ORPHA:2237	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SKAP1
Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome ORPHA:293864	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ISL1
Hypotrichosis with juvenile macular degeneration ORPHA:1573	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
IVIC syndrome ORPHA:2307	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FGF19
Idiopathic CD4 lymphocytopenia ORPHA:228000	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Immunodeficiency due to MASP-2 deficiency ORPHA:331187	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DNHD1
Immunodeficiency due to ficolin3 deficiency ORPHA:331190	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	HYAL1
Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency ORPHA:70592	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Incontinentia pigmenti ORPHA:464	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Infant acute respiratory distress syndrome ORPHA:70587	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Infantile Bartter syndrome with sensorineural deafness ORPHA:89938	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PBX1
Infantile dystonia-parkinsonism ORPHA:238455	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FGF19
Infantile epileptic-dyskinetic encephalopathy ORPHA:364063	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency ORPHA:352563	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Infantile osteopetrosis with neuroaxonal dysplasia ORPHA:85179	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OSTM1
Infantile-onset X-linked spinal muscular atrophy ORPHA:1145	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Infantile-onset ascending hereditary spastic paralysis ORPHA:293168	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SCHIP1
Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression ORPHA:391316	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Inherited Creutzfeldt-Jakob disease ORPHA:282166	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCEH1
Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency ORPHA:289548	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
Intellectual disability, Birk-Barel type ORPHA:166108	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Intellectual disability-developmental delay-contractures syndrome ORPHA:3454	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Intellectual disability-epilepsy-extrapyramidal syndrome ORPHA:468620	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Intellectual disability-expressive aphasia-facial dysmorphism syndrome ORPHA:436151	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PBX1
Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome ORPHA:457279	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYO15B
Intellectual disability-strabismus syndrome ORPHA:363528	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Intermediate epidermolysis bullosa simplex with cardiomyopathy ORPHA:508529	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CPEB4
Isobutyryl-CoA dehydrogenase deficiency ORPHA:79159	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C11ORF71
Isolated Dandy-Walker malformation ORPHA:217	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	COL5A2
Isolated asymptomatic elevation of creatine phosphokinase ORPHA:206599	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADPRHL1
Isolated cloverleaf skull syndrome ORPHA:2343	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Isolated congenital megalocornea ORPHA:91489	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Isolated focal cortical dysplasia type Ia ORPHA:268973	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TRIB3
Isolated megalencephaly ORPHA:268920	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SPC25
Isolated optic nerve hypoplasia/aplasia ORPHA:137902	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Isolated oxycephaly ORPHA:63440	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Isolated sedoheptulokinase deficiency ORPHA:440713	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Isolated thyrotropin-releasing hormone deficiency ORPHA:238670	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Juvenile sialidosis type 2 ORPHA:93399	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NEU1
Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome ORPHA:445062	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CASP7
KCNQ2-related epileptic encephalopathy ORPHA:439218	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Keppen-Lubinsky syndrome ORPHA:435628	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR137C
Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome ORPHA:281201	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Ketoacidosis due to monocarboxylate transporter-1 deficiency ORPHA:438075	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Keutel syndrome ORPHA:85202	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
King-Denborough syndrome ORPHA:99741	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CA11
Kleefstra syndrome due to 9q34 microdeletion ORPHA:96147	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TFAP4
Kniest dysplasia ORPHA:485	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Koolen-De Vries syndrome due to a point mutation ORPHA:363965	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DNHD1
Kufor-Rakeb syndrome ORPHA:306674	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Kuru ORPHA:454745	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCEH1
Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency ORPHA:1900	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
L-Arginine:glycine amidinotransferase deficiency ORPHA:35704	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
L-ferritin deficiency ORPHA:440731	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
LIPE-related familial partial lipodystrophy ORPHA:435660	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
LMNA-related cardiocutaneous progeria syndrome ORPHA:363618	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Late-onset distal myopathy, Markesbery-Griggs type ORPHA:98912	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADPRHL1
Laurence-Moon syndrome ORPHA:2377	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Legg-Calve-Perthes disease ORPHA:2380	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Lenz-Majewski hyperostotic dwarfism ORPHA:2658	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Lethal brain and heart developmental defects ORPHA:580933	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Lethal congenital contracture syndrome type 1 ORPHA:1486	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome ORPHA:478049	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
Lethal neonatal spasticity-epileptic encephalopathy syndrome ORPHA:435845	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Leukocyte adhesion deficiency type I ORPHA:99842	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Leukocyte adhesion deficiency type II ORPHA:99843	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Leukocyte adhesion deficiency type III ORPHA:99844	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome ORPHA:314051	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Leydig cell hypoplasia due to complete LH resistance ORPHA:96265	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Leydig cell hypoplasia due to partial LH resistance ORPHA:96266	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Low isolated anorectal malformation ORPHA:171215	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
Low phospholipid-associated cholelithiasis ORPHA:69663	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ABCB1
MEGDEL syndrome ORPHA:352328	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR137C
MOGS-CDG ORPHA:79330	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
MRCS syndrome ORPHA:263347	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	P2RX7
MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome ORPHA:498693	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Macular corneal dystrophy ORPHA:98969	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACBD7
Malonic aciduria ORPHA:943	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYO15B
Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CCND1
Mazabraud syndrome ORPHA:57782	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
McCune-Albright syndrome ORPHA:562	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
Medulloblastoma with extensive nodularity ORPHA:251858	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
Megaconial congenital muscular dystrophy ORPHA:280671	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYO15B
Megacystis-microcolon-intestinal hypoperistalsis syndrome ORPHA:2241	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Melnick-Needles syndrome ORPHA:2484	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Metabolic myopathy due to lactate transporter defect ORPHA:171690	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Metaphyseal chondrodysplasia, Jansen type ORPHA:33067	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria ORPHA:99646	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PIR
Methylcobalamin deficiency type cblE ORPHA:2169	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
Methylmalonic acidemia with homocystinuria type cblF ORPHA:79284	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	KAT2B
Methylmalonic acidemia with homocystinuria, type cblC ORPHA:79282	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SPC25
Methylmalonic acidemia with homocystinuria, type cblJ ORPHA:369955	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYO15B
Microcephalic osteodysplastic dysplasia, Saul-Wilson type ORPHA:85172	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Microcephalic primordial dwarfism due to ZNF335 deficiency ORPHA:329228	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Microcephalic primordial dwarfism, Dauber type ORPHA:319675	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DOCK11
Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom ORPHA:500159	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome ORPHA:423306	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Microcytic anemia with liver iron overload ORPHA:83642	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EHF
Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis ORPHA:93279	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Minimal pigment oculocutaneous albinism type 1 ORPHA:352734	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPNMB
Mirror-image polydactyly ORPHA:498494	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SIX2
Mitochondrial pyruvate carrier deficiency ORPHA:447784	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C11ORF71
Moderate multiminicore disease with hand involvement ORPHA:178145	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CA11
Monosomy 9q22.3 ORPHA:77301	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TET1
Monostotic fibrous dysplasia ORPHA:93277	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
Morning glory disc anomaly ORPHA:35737	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Mucopolysaccharidosis type 2, attenuated form ORPHA:217093	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PDE4B
Mucopolysaccharidosis type 2, severe form ORPHA:217085	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PDE4B
Mucopolysaccharidosis type 4B ORPHA:309310	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NEU1
Mucopolysaccharidosis type 6, rapidly progressing ORPHA:276212	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OSTM1
Mucopolysaccharidosis type 6, slowly progressing ORPHA:276223	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OSTM1
Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders ORPHA:505248	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Mulibrey nanism ORPHA:2576	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FAM234B
Multiple congenital anomalies-hypotonia-seizures syndrome ORPHA:280633	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
Multiple epiphyseal dysplasia type 1 ORPHA:93308	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Multiple epiphyseal dysplasia type 4 ORPHA:93307	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ITGA2
Multiple epiphyseal dysplasia, Beighton type ORPHA:166011	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Multiple self-healing squamous epithelioma ORPHA:65748	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DOCK11
Multiple symmetric lipomatosis ORPHA:2398	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality ORPHA:86841	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
NEK9-related lethal skeletal dysplasia ORPHA:464366	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DNHD1
NIK deficiency ORPHA:447731	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
NON RARE IN EUROPE: Ankylosing spondylitis ORPHA:825	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
NON RARE IN EUROPE: Brachydactyly type D ORPHA:93385	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ISL1
NON RARE IN EUROPE: Glucose-6-phosphate-dehydrogenase deficiency ORPHA:362	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
NON RARE IN EUROPE: Immunoglobulin A deficiency ORPHA:69127	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CD22
NON RARE IN EUROPE: Patent arterial duct ORPHA:706	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
NTHL1-related attenuated familial adenomatous polyposis ORPHA:454840	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MRM1
Naegeli-Franceschetti-Jadassohn syndrome ORPHA:69087	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
Nasopharyngeal carcinoma ORPHA:150	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Nephrogenic syndrome of inappropriate antidiuresis ORPHA:93606	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Netherton syndrome ORPHA:634	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
Neuralgic amyotrophy ORPHA:2901	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Neuroectodermal melanolysosomal disease ORPHA:33445	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC4A8
Neuroferritinopathy ORPHA:157846	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Neurogenic scapuloperoneal syndrome, Kaeser type ORPHA:85146	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Neuronal intestinal pseudoobstruction ORPHA:99811	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Nevus comedonicus syndrome ORPHA:64754	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DNHD1
Null syndrome ORPHA:280234	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Obesity due to SIM1 deficiency ORPHA:369873	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	VGLL3
Obesity due to congenital leptin deficiency ORPHA:66628	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SYNE3
Obesity due to leptin receptor gene deficiency ORPHA:179494	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PLSCR4
Obesity due to melanocortin 4 receptor deficiency ORPHA:71529	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SCG2
Occult macular dystrophy ORPHA:247834	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PLEKHD1
Ocular anomalies-axonal neuropathy-developmental delay syndrome ORPHA:496790	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Oculocerebrofacial syndrome, Kaufman type ORPHA:2707	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TRAK2
Oculocutaneous albinism type 1A ORPHA:79431	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPNMB
Oculocutaneous albinism type 1B ORPHA:79434	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPNMB
Oculocutaneous albinism type 4 ORPHA:79435	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LZTS1
Oculocutaneous albinism type 6 ORPHA:370097	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LZTS1
Okihiro syndrome due to 20q13 microdeletion ORPHA:261638	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FGF19
Okihiro syndrome due to a point mutation ORPHA:261647	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FGF19
Oligodontia-cancer predisposition syndrome ORPHA:300576	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LRIG1
Opsismodysplasia ORPHA:2746	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Ornithine transcarbamylase deficiency ORPHA:664	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CYP4F2
Orofaciodigital syndrome type 4 ORPHA:2753	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Osteocraniostenosis ORPHA:2763	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Osteopetrosis with renal tubular acidosis ORPHA:2785	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CA2
Otopalatodigital syndrome type 1 ORPHA:90650	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Otopalatodigital syndrome type 2 ORPHA:90652	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Otospondylomegaepiphyseal dysplasia ORPHA:1427	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CNTNAP1
PGM3-CDG ORPHA:443811	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	RHOBTB3
PLAA-associated neurodevelopmental disorder ORPHA:521426	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement ORPHA:79401	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADAM15
PLIN1-related familial partial lipodystrophy ORPHA:280356	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
POMGNT1-related  limb-girdle muscular dystrophy R15 ORPHA:206564	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
POMT2-related  limb-girdle muscular dystrophy R14 ORPHA:206559	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CA11
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation ORPHA:438216	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CPEB4
PYCR1-related De Barsy syndrome ORPHA:293633	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
PYCR2-related microcephaly-progressive leukoencephalopathy ORPHA:481152	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MRM1
Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome ORPHA:477993	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Pancytopenia due to IKZF1 mutations ORPHA:317473	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	E2F7
Partington syndrome ORPHA:94083	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Peeling skin syndrome type B ORPHA:263553	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
Pelizaeus-Merzbacher disease in female carriers ORPHA:280229	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Pelizaeus-Merzbacher disease, classic form ORPHA:280219	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Pelizaeus-Merzbacher disease, connatal form ORPHA:280210	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Pelizaeus-Merzbacher disease, transitional form ORPHA:280224	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FAM219A
Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome ORPHA:397744	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
Perlman syndrome ORPHA:2849	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DNHD1
Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome ORPHA:65288	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Perry syndrome ORPHA:178509	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FAM219A
Phakomatosis pigmentokeratotica ORPHA:2874	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Phosphoserine aminotransferase deficiency, infantile/juvenile form ORPHA:284417	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Pigmented paravenous retinochoroidal atrophy ORPHA:251295	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Platyspondylic dysplasia, Torrance type ORPHA:85166	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Plectin-related  limb-girdle muscular dystrophy R17 ORPHA:254361	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADAM15
Polycythemia vera ORPHA:729	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	KAT2B
Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Polymicrogyria due to TUBB2B mutation ORPHA:300573	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Polyostotic fibrous dysplasia ORPHA:93276	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
Porencephaly-microcephaly-bilateral congenital cataract syndrome ORPHA:306547	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LZTS1
Postaxial acrofacial dysostosis ORPHA:246	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TFAP4
Posterior column ataxia-retinitis pigmentosa syndrome ORPHA:88628	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ESCO2
PrP systemic amyloidosis ORPHA:397606	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCEH1
Predisposition to invasive fungal disease due to CARD9 deficiency ORPHA:457088	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Primary failure of tooth eruption ORPHA:412206	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
Primary familial polycythemia ORPHA:90042	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	BBC3
Primary hyperaldosteronism-seizures-neurological abnormalities syndrome ORPHA:369929	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCALD
Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome ORPHA:306558	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Progeroid syndrome, Petty type ORPHA:2963	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TPM4
Progressive epilepsy-intellectual disability syndrome, Finnish type ORPHA:1947	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DRAXIN
Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome ORPHA:457212	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Progressive familial intrahepatic cholestasis type 3 ORPHA:79305	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ABCB1
Progressive familial intrahepatic cholestasis type 5 ORPHA:480476	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CYP4F2
Progressive myoclonic epilepsy type 7 ORPHA:435438	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Progressive myoclonic epilepsy type 8 ORPHA:424027	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
Progressive myoclonic epilepsy type 9 ORPHA:457265	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Progressive osseous heteroplasia ORPHA:2762	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
Progressive polyneuropathy with bilateral striatal necrosis ORPHA:217396	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MICB
Progressive scapulohumeroperoneal distal myopathy ORPHA:447977	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADPRHL1
Progressive supranuclear palsy-corticobasal syndrome ORPHA:240103	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Progressive supranuclear palsy-parkinsonism syndrome ORPHA:240085	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Progressive supranuclear palsy-progressive non-fluent aphasia syndrome ORPHA:240112	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Progressive supranuclear palsy-pure akinesia with gait freezing syndrome ORPHA:240094	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Prolidase deficiency ORPHA:742	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Proximal myopathy with extrapyramidal signs ORPHA:401768	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	HSDL2
Proximal myopathy with focal depletion of mitochondria ORPHA:521305	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYO15B
Prune belly syndrome ORPHA:2970	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CNTNAP2
Pseudoachondroplasia ORPHA:750	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Pseudohypoparathyroidism type 1A ORPHA:79443	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
Pseudohypoparathyroidism type 1C ORPHA:79444	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
Pseudopseudohypoparathyroidism ORPHA:79445	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
Pulmonary arterial hypertension associated with connective tissue disease ORPHA:275798	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Purine nucleoside phosphorylase deficiency ORPHA:760	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MICB
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome ORPHA:69126	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Pyruvate carboxylase deficiency, benign type ORPHA:353320	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
Pyruvate carboxylase deficiency, infantile type ORPHA:353308	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
Pyruvate carboxylase deficiency, severe neonatal type ORPHA:353314	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
Pyruvate dehydrogenase E2 deficiency ORPHA:79244	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
RFVT2-related riboflavin transporter deficiency ORPHA:572543	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
Rapid-onset dystonia-parkinsonism ORPHA:71517	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome ORPHA:280384	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Recessive mitochondrial ataxia syndrome ORPHA:94125	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Renal tubulopathy-encephalopathy-liver failure syndrome ORPHA:254902	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MRM1
Renin-angiotensin-aldosterone system-blocker-induced angioedema ORPHA:100057	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CYP4F2
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FAM219A
Resistance to thyrotropin-releasing hormone syndrome ORPHA:99832	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TET1
Retinal macular dystrophy type 2 ORPHA:319640	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PBX1
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Rhizomelic chondrodysplasia punctata type 5 ORPHA:468717	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Right sided atrial isomerism ORPHA:97548	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	C1QL1
Rippling muscle disease ORPHA:97238	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADPRHL1
S-adenosylhomocysteine hydrolase deficiency ORPHA:88618	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
SHORT syndrome ORPHA:3163	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	KAT2B
SIM1-related Prader-Willi-like syndrome ORPHA:398079	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	VGLL3
SLC35A2-CDG ORPHA:356961	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TRIB3
SRD5A3-CDG ORPHA:324737	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PIR
STAT3-related early-onset multisystem autoimmune disease ORPHA:438159	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
STING-associated vasculopathy with onset in infancy ORPHA:425120	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Saccharopinuria ORPHA:3124	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
Scheie syndrome ORPHA:93474	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Schilbach-Rott syndrome ORPHA:2353	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TET1
Schinzel-Giedion syndrome ORPHA:798	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PBX1
Scott syndrome ORPHA:806	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TPM4
Seborrhea-like dermatitis with psoriasiform elements ORPHA:168606	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
Seizures-scoliosis-macrocephaly syndrome ORPHA:466926	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Severe combined immunodeficiency due to DNA-PKcs deficiency ORPHA:317425	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CENPE
Severe combined immunodeficiency due to FOXN1 deficiency ORPHA:169095	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	S100A14
Severe combined immunodeficiency due to adenosine deaminase deficiency ORPHA:277	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MICB
Severe early-onset axonal neuropathy due to MFN2 deficiency ORPHA:90118	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency ORPHA:440427	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TRIB3
Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome ORPHA:488627	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Severe hereditary thrombophilia due to congenital protein C deficiency ORPHA:745	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CYP4F2
Severe myopia-generalized joint laxity-short stature syndrome ORPHA:527450	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SMIM13
Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion ORPHA:314655	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CPEB4
Short stature due to growth hormone qualitative anomaly ORPHA:629	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CD22
Short stature-advanced bone age-early-onset osteoarthritis syndrome ORPHA:435804	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LZTS1
Short stature-optic atrophy-Pelger-Huet anomaly syndrome ORPHA:391677	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TET1
Sialidosis type 1 ORPHA:812	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NEU1
Sinoatrial node dysfunction and deafness ORPHA:324321	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCALD
Spastic paraplegia type 2 ORPHA:99015	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Spastic paraplegia-severe developmental delay-epilepsy syndrome ORPHA:464282	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR137C
Spectrin-associated autosomal recessive cerebellar ataxia ORPHA:352403	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR37
Spinal muscular atrophy with respiratory distress type 1 ORPHA:98920	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Spinal muscular atrophy with respiratory distress type 2 ORPHA:404521	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Spinocerebellar ataxia type 14 ORPHA:98763	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Spinocerebellar ataxia type 19/22 ORPHA:98772	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORBS1
Spinocerebellar ataxia type 26 ORPHA:101112	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Spinocerebellar ataxia type 31 ORPHA:217012	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PLEKHD1
Spinocerebellar ataxia type 36 ORPHA:276198	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NOLC1
Spinocerebellar ataxia type 41 ORPHA:458798	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZCCHC12
Spinocerebellar ataxia type 42 ORPHA:458803	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
Spinocerebellar ataxia type 5 ORPHA:98766	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR37
Spinocerebellar ataxia type 6 ORPHA:98758	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SLC4A8
Spinocerebellar ataxia with epilepsy ORPHA:254881	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Spondyloepimetaphyseal dysplasia congenita, Strudwick type ORPHA:93346	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Spondyloepimetaphyseal dysplasia with multiple dislocations ORPHA:93360	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OIP5
Spondyloepimetaphyseal dysplasia, aggrecan type ORPHA:171866	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LZTS1
Spondyloepiphyseal dysplasia congenita ORPHA:94068	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Spondyloepiphyseal dysplasia with metatarsal shortening ORPHA:137678	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Spondyloepiphyseal dysplasia, Kimberley type ORPHA:93283	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LZTS1
Spondyloepiphyseal dysplasia, Stanescu type ORPHA:459051	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Spondylometaphyseal dysplasia, Schmidt type ORPHA:93316	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome ORPHA:85167	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FRMD8
Spondyloperipheral dysplasia-short ulna syndrome ORPHA:1856	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Sporadic fatal insomnia ORPHA:586130	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	NCEH1
Stapes ankylosis with broad thumbs and toes ORPHA:140917	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYBL1
Stickler syndrome type 1 ORPHA:90653	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
Supravalvular aortic stenosis ORPHA:3193	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACTA2
Susceptibility to infection due to TYK2 deficiency ORPHA:331226	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Susceptibility to respiratory infections associated with CD8alpha chain mutation ORPHA:169085	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SKAP1
Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Symptomatic form of Coffin-Lowry syndrome in female carriers ORPHA:276630	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ACSL5
Syndactyly type 5 ORPHA:93406	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ISL1
Syndromic sensorineural deafness due to combined oxidative phosphorylation defect ORPHA:457223	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Synpolydactyly type 1 ORPHA:295195	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ISL1
T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency ORPHA:169154	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
T-B+ severe combined immunodeficiency due to JAK3 deficiency ORPHA:35078	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
T-B+ severe combined immunodeficiency due to gamma chain deficiency ORPHA:276	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
T-cell large granular lymphocyte leukemia ORPHA:86872	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
TELO2-related intellectual disability-neurodevelopmental disorder ORPHA:488642	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZBTB45
TMEM70-related mitochondrial encephalo-cardio-myopathy ORPHA:1194	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
TOR1AIP1-related limb-girdle muscular dystrophy ORPHA:424261	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OSTM1
Tarsal-carpal coalition syndrome ORPHA:1412	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYBL1
Tatton-Brown-Rahman syndrome ORPHA:404443	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	DRAXIN
Temperature-sensitive oculocutaneous albinism type 1 ORPHA:352737	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPNMB
Terminal osseous dysplasia-pigmentary defects syndrome ORPHA:88630	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
Testicular regression syndrome ORPHA:983	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MRM1
Thrombocytopenia-absent radius syndrome ORPHA:3320	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TOMM22
Trichomegaly-retina pigmentary degeneration-dwarfism syndrome ORPHA:3363	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
Tyrosinemia type 1 ORPHA:882	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ABHD14B
VACTERL/VATER association ORPHA:887	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ISL1
Variant ABeta2M amyloidosis ORPHA:314652	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Vitamin B12-unresponsive methylmalonic acidemia type mut- ORPHA:79312	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	HSDL2
Vitamin B12-unresponsive methylmalonic acidemia type mut0 ORPHA:289916	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	HSDL2
Von Hippel-Lindau disease ORPHA:892	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TFAP4
WARS2-related combined oxidative phosphorylation defect ORPHA:572798	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
WHIM syndrome ORPHA:51636	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Waldenstrom macroglobulinemia ORPHA:33226	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PSMB9
Wilson disease ORPHA:905	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	LIFR
Wolman disease ORPHA:75233	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CTSD
Woolly hair nevus ORPHA:79414	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	PPP1R14B
X-linked Charcot-Marie-Tooth disease type 6 ORPHA:352675	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	SORL1
X-linked Ehlers-Danlos syndrome ORPHA:75497	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
X-linked congenital generalized hypertrichosis ORPHA:79495	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
X-linked dominant chondrodysplasia, Chassaing-Lacombe type ORPHA:163966	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	MYO15B
X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome ORPHA:500188	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
X-linked intellectual disability with isolated growth hormone deficiency ORPHA:67045	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	TMSB15A
X-linked intellectual disability, Hedera type ORPHA:93952	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OSTM1
X-linked intellectual disability, Najm type ORPHA:163937	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	AMOTL2
X-linked intellectual disability, Nascimento type ORPHA:163956	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ARL2BP
X-linked intellectual disability, Snyder type ORPHA:3063	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OIP5
X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome ORPHA:324410	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	P2RX7
X-linked intellectual disability-cerebellar hypoplasia syndrome ORPHA:137831	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR137C
X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome ORPHA:482606	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GANAB
X-linked lissencephaly with abnormal genitalia ORPHA:452	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OGFR
X-linked parkinsonism-spasticity syndrome ORPHA:363654	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	OSTM1
X-linked recessive ocular albinism ORPHA:54	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	GPR37
X-linked severe congenital neutropenia ORPHA:86788	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
X-linked sideroblastic anemia and spinocerebellar ataxia ORPHA:2802	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ZW10
X-linked spasticity-intellectual disability-epilepsy syndrome ORPHA:3175	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	EFR3B
X-linked thrombocytopenia with normal platelets ORPHA:852	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	CORO1A
Young adult-onset distal hereditary motor neuropathy ORPHA:314485	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	FAM219A
Zebra body myopathy ORPHA:97240	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ADPRHL1
Zygodactyly type 3 ORPHA:295191	1/101	0.6770344286552836	0.7068064785325423	0	0	0.8904072398190045	0.3472883428697405	ISL1
17q12 microdeletion syndrome ORPHA:261265	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	FGF19
Acrodermatitis continua of Hallopeau ORPHA:163931	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	EHF
Acute basophilic leukemia ORPHA:86849	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CORO1A
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) ORPHA:402020	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	PRR15
Acute myeloid leukemia with t(6;9)(p23;q34) ORPHA:402014	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CLSPN
Adenosine monophosphate deaminase deficiency ORPHA:45	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ACSL5
Amelocerebrohypohidrotic syndrome ORPHA:1946	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	SULT1A1
Anaplastic oligodendroglioma ORPHA:251630	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	OIP5
Andersen-Tawil syndrome ORPHA:37553	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	P2RX7
Angelman syndrome due to maternal 15q11q13 deletion ORPHA:98794	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	TET1
Aniridia-cerebellar ataxia-intellectual disability syndrome ORPHA:1065	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CCSAP
Antley-Bixler syndrome ORPHA:83	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	S100A14
Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis ORPHA:329173	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	OGFR
Autosomal dominant hypocalcemia ORPHA:428	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	AMOTL2
Autosomal recessive sideroblastic anemia ORPHA:260305	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	NOLC1
Benign hereditary chorea ORPHA:1429	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	LIFR
Bernard-Soulier syndrome ORPHA:274	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	NRGN
Brachydactyly-elbow wrist dysplasia syndrome ORPHA:1275	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	SIX2
Brittle cornea syndrome ORPHA:90354	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	VGLL3
CADDS ORPHA:369942	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CTSD
CHARGE syndrome ORPHA:138	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CNTNAP2
Carpenter syndrome ORPHA:65759	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	AMOTL2
Cerebellar ataxia-hypogonadism syndrome ORPHA:1173	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	OGFR
Cerebrofacioarticular syndrome ORPHA:314679	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	COL5A2
Cholesterol-ester transfer protein deficiency ORPHA:79506	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CYP4F2
Classic maple syrup urine disease ORPHA:268145	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	HSDL2
Cole-Carpenter syndrome ORPHA:2050	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	GANAB
Congenital bilateral absence of vas deferens ORPHA:48	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	PBX1
Congenital neutropenia-myelofibrosis-nephromegaly syndrome ORPHA:369852	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	FAM234B
Congenital sodium diarrhea ORPHA:103908	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	MYO15B
Crisponi syndrome ORPHA:1545	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	TNFSF9
Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ZBTB45
Deafness-enamel hypoplasia-nail defects syndrome ORPHA:3220	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	DNHD1
Deletion 5q35 ORPHA:1627	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	TET1
Dense deposit disease ORPHA:93571	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	PLSCR4
Desmoplastic small round cell tumor ORPHA:83469	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	NOLC1
Ependymoma ORPHA:251636	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	FRMD8
Familial isolated pituitary adenoma ORPHA:314777	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CORO1A
Familial porphyria cutanea tarda ORPHA:443062	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ABHD14B
Fever-associated acute infantile liver failure syndrome ORPHA:464724	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ZW10
Generalized pustular psoriasis ORPHA:247353	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	EHF
Geroderma osteodysplastica ORPHA:2078	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	E2F7
Glycogen storage disease due to muscle phosphorylase kinase deficiency ORPHA:715	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ADPRHL1
Hartnup disease ORPHA:2116	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CYP4F2
Hemimegalencephaly ORPHA:99802	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ZBTB18
Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia ORPHA:313808	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	MYO15B
Hereditary renal hypouricemia ORPHA:94088	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ACSL5
Hutchinson-Gilford progeria syndrome ORPHA:740	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CCND1
Hydrolethalus ORPHA:2189	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	E2F7
Hypertrichotic osteochondrodysplasia, Cantu type ORPHA:1517	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	SORBS1
Hypotonia-speech impairment-severe cognitive delay syndrome ORPHA:371364	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	GPR137C
Ichthyosis-short stature-brachydactyly-microspherophakia syndrome ORPHA:363992	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	SUSD4
Idiopathic ventricular fibrillation, non Brugada type ORPHA:228140	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	EFR3B
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia ORPHA:52430	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	NOLC1
Infantile Krabbe disease ORPHA:206436	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CTSD
Intermediate osteopetrosis ORPHA:210110	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	OGFR
Intermittent maple syrup urine disease ORPHA:268173	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	HSDL2
Isolated congenitally uncorrected transposition of the great arteries ORPHA:216718	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CNTNAP2
Isolated focal non-epidermolytic palmoplantar keratoderma ORPHA:448264	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	S100A14
Kabuki syndrome ORPHA:2322	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	DNHD1
Leigh syndrome with nephrotic syndrome ORPHA:255249	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	TOMM22
Lethal congenital contracture syndrome type 3 ORPHA:137783	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	FAM219A
MEDNIK syndrome ORPHA:171851	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	GANAB
Macrocephaly-intellectual disability-autism syndrome ORPHA:210548	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	NCALD
Microphthalmia, Lenz type ORPHA:568	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	NOLC1
Moyamoya disease ORPHA:2573	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ACTA2
Multiple benign circumferential skin creases on limbs ORPHA:2505	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	TMSB15A
Musculocontractural Ehlers-Danlos syndrome ORPHA:2953	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	TPM4
Neonatal severe primary hyperparathyroidism ORPHA:417	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	EHF
Nephrogenic diabetes insipidus ORPHA:223	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	MYO15B
Null pituitary adenoma ORPHA:314790	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ZBTB45
Occipital pachygyria and polymicrogyria ORPHA:280640	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	EFR3B
Oguchi disease ORPHA:75382	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	PLEKHD1
Oligodendroglioma ORPHA:251627	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	OIP5
Otofaciocervical syndrome ORPHA:2792	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	GPR137C
Paroxysmal exertion-induced dyskinesia ORPHA:98811	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	C1QL1
Paternal uniparental disomy of chromosome 6 ORPHA:96191	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ENG
Persistent Mullerian duct syndrome ORPHA:2856	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	SCML2
Phosphoenolpyruvate carboxykinase deficiency ORPHA:2880	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CYP4F2
Pituitary gigantism ORPHA:99725	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ZBTB45
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection ORPHA:431166	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	PSMB9
Pure hair and nail ectodermal dysplasia ORPHA:69084	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	PADI3
Pustulosis palmaris et plantaris ORPHA:163927	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	EHF
RELA fusion-positive ependymoma ORPHA:530792	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	FRMD8
Restrictive dermopathy ORPHA:1662	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CCND1
Rigid spine syndrome ORPHA:97244	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ADPRHL1
Schneckenbecken dysplasia ORPHA:3144	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	GANAB
Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome ORPHA:70595	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	OGFR
Silent pituitary adenoma ORPHA:314786	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	ZBTB45
Spinocerebellar ataxia type 37 ORPHA:363710	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CNTNAP2
Stevens-Johnson syndrome ORPHA:36426	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CORO1A
Stormorken-Sjaastad-Langslet syndrome ORPHA:3204	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	FRMD8
Striate palmoplantar keratoderma ORPHA:50942	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	S100A14
Syndromic diarrhea ORPHA:84064	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	GANAB
Thiamine-responsive maple syrup urine disease ORPHA:268184	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	HSDL2
Thyroid ectopia ORPHA:95712	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	RPSAP52
Townes-Brocks syndrome ORPHA:857	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	GLI2
Vogt-Koyanagi-Harada disease ORPHA:3437	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	PSMB9
Wilson-Turner syndrome ORPHA:3459	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	NOLC1
Wiskott-Aldrich syndrome ORPHA:906	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	CORO1A
X-linked hypohidrotic ectodermal dysplasia ORPHA:181	1/102	0.6806375269696956	0.7068064785325423	0	0	0.8815465256932933	0.33915332240809754	COL5A2
46,XX ovotesticular disorder of sex development ORPHA:2138	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	AMOTL2
Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome ORPHA:86818	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	MICB
Alveolar rhabdomyosarcoma ORPHA:99756	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	PBX1
Autosomal dominant epilepsy with auditory features ORPHA:101046	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	GPR137C
Autosomal recessive chorioretinopathy-microcephaly syndrome ORPHA:2518	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	CLSPN
Autosomal recessive cutis laxa type 2, classic type ORPHA:357074	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	OSTM1
Childhood-onset nemaline myopathy ORPHA:171439	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	ADPRHL1
Cold-induced sweating syndrome ORPHA:157820	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	RPSAP52
Congenital fibrosis of extraocular muscles ORPHA:45358	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	SCG2
Duane retraction syndrome ORPHA:233	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	PBX1
Familial Chilblain lupus ORPHA:481662	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	PSMB9
Familial focal epilepsy with variable foci ORPHA:98820	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	CORO1A
Familial hypercholanemia ORPHA:238475	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	AMOTL2
Familial isolated hyperparathyroidism ORPHA:99879	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	NOLC1
Familial thrombocytosis ORPHA:71493	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	KAT2B
Female infertility due to oocyte meiotic arrest ORPHA:488191	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	SKAP1
Female infertility due to zona pellucida defect ORPHA:404466	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	PLEKHD1
Gorlin syndrome ORPHA:377	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	CNTNAP1
Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome ORPHA:88637	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	NOLC1
Immunodeficiency by defective expression of MHC class II ORPHA:572	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	CORO1A
Isolated microphthalmia-anophthalmia-coloboma ORPHA:2542	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	TMSB15A
Isolated polycystic liver disease ORPHA:2924	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	GANAB
Isolated scaphocephaly ORPHA:35093	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	SMAD6
Mantle cell lymphoma ORPHA:52416	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	CCND1
Microphthalmia with linear skin defects syndrome ORPHA:2556	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	TOMM22
Miller-Dieker syndrome ORPHA:531	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	FAM219A
Mitochondrial neurogastrointestinal encephalomyopathy ORPHA:298	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	OGFR
Muir-Torre syndrome ORPHA:587	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	DEPDC1B
NON RARE IN EUROPE: Barrett esophagus ORPHA:1232	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	GPNMB
NON RARE IN EUROPE: Hidradenitis suppurativa ORPHA:387	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	NEU1
NON RARE IN EUROPE: Tourette syndrome ORPHA:856	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	NCALD
Osteogenesis imperfecta ORPHA:666	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	CCND1
Pediatric systemic lupus erythematosus ORPHA:93552	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	CTSD
Preeclampsia ORPHA:275555	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	SORBS1
Primary sclerosing cholangitis ORPHA:171	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	MYO15B
Progressive cone dystrophy ORPHA:1871	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	GPR137C
Prolactinoma ORPHA:2965	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	OGFR
Takayasu arteritis ORPHA:3287	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	PSMB9
Thyroid hypoplasia ORPHA:95720	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	ACSL5
Triple A syndrome ORPHA:869	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	GANAB
Tubular aggregate myopathy ORPHA:2593	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	MKNK2
Waardenburg-Shah syndrome ORPHA:897	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	SORBS1
X-linked non-syndromic sensorineural deafness type DFN ORPHA:90625	1/103	0.684200606813462	0.7068064785325423	0	0	0.8728595510602432	0.33125379541083527	RBM24
Atypical glycine encephalopathy ORPHA:289863	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	GPR37
Autosomal dominant hypohidrotic ectodermal dysplasia ORPHA:1810	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	SKAP1
Autosomal dominant severe congenital neutropenia ORPHA:486	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	CORO1A
Autosomal recessive malignant osteopetrosis ORPHA:667	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	CORO1A
Cardiofaciocutaneous syndrome ORPHA:1340	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	ZBTB18
Chronic myelomonocytic leukemia ORPHA:98823	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	ENG
Complete hydatidiform mole ORPHA:254688	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	CORO1A
Early-onset anterior polar cataract ORPHA:98988	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	IL22RA1
Familial congenital mirror movements ORPHA:238722	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	TMSB15A
Familial hemophagocytic lymphohistiocytosis ORPHA:540	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	CORO1A
Giant cell arteritis ORPHA:397	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	PSMB9
Idiopathic achalasia ORPHA:930	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	P2RX7
Infantile glycine encephalopathy ORPHA:289860	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	GPR37
Juvenile amyotrophic lateral sclerosis ORPHA:300605	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	GANAB
MALT lymphoma ORPHA:52417	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	PSMB9
NON RARE IN EUROPE: Dementia with Lewy body ORPHA:1648	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	CHST1
NON RARE IN EUROPE: Essential hypertension ORPHA:243761	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	SORBS1
NON RARE IN EUROPE: FG syndrome phenotypic spectrum ORPHA:323	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	CENPE
Narcolepsy type 2 ORPHA:83465	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	CORO1A
Progressive symmetric erythrokeratodermia ORPHA:316	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	S100A14
Renal tubular dysgenesis of genetic origin ORPHA:97369	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	PLSCR4
Shwachman-Diamond syndrome ORPHA:811	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	ZW10
Smith-Magenis syndrome ORPHA:819	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	ZBTB45
Squamous cell carcinoma of the esophagus ORPHA:99977	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	ACSL5
Typical nemaline myopathy ORPHA:171436	1/104	0.6877241108163017	0.7068064785325423	0	0	0.8643412555462813	0.3235812950315037	RBM24
Aggressive systemic mastocytosis ORPHA:98850	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	TLR6
Atypical Rett syndrome ORPHA:3095	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	EFR3B
Autosomal agammaglobulinemia ORPHA:33110	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	CORO1A
Autosomal dominant centronuclear myopathy ORPHA:169189	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	MKNK2
Autosomal dominant macrothrombocytopenia ORPHA:140957	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	TPM4
Autosomal recessive Stickler syndrome ORPHA:250984	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	LZTS1
Autosomal recessive spondylocostal dysostosis ORPHA:2311	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	C1QL1
Autosomal systemic lupus erythematosus ORPHA:300345	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	MYO15B
Chronic mucocutaneous candidiasis ORPHA:1334	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	PSMB9
Coloboma of choroid and retina ORPHA:98942	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	C1QL1
Coloboma of iris ORPHA:98944	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	C1QL1
Extraskeletal myxoid chondrosarcoma ORPHA:209916	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	GANAB
Fatal infantile cytochrome C oxidase deficiency ORPHA:1561	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	TOMM22
Hyperphosphatasia-intellectual disability syndrome ORPHA:247262	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	MRM1
Idiopathic aplastic anemia ORPHA:88	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	SKAP1
Myoclonus-dystonia syndrome ORPHA:36899	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	C1QL1
NON RARE IN EUROPE: Ulcerative colitis ORPHA:771	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	ABCB1
Nanophthalmos ORPHA:35612	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	EFR3B
Usher syndrome type 2 ORPHA:231178	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	CNTNAP2
Usher syndrome type 3 ORPHA:231183	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	PLEKHD1
Uveal melanoma ORPHA:39044	1/105	0.6912084764757694	0.7068064785325423	0	0	0.8559867734075879	0.3161277264513347	ZBTB18
Cervical spina bifida aperta ORPHA:268392	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Cervical spina bifida cystica ORPHA:268762	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Cervicothoracic spina bifida aperta ORPHA:268397	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Cervicothoracic spina bifida cystica ORPHA:268766	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Clear cell sarcoma of kidney ORPHA:457246	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	NOLC1
Congenital generalized lipodystrophy ORPHA:528	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	CTSD
Essential thrombocythemia ORPHA:3318	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	TLR6
Hoyeraal-Hreidarsson syndrome ORPHA:3322	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	MRM1
Inflammatory myofibroblastic tumor ORPHA:178342	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	TPM4
Juvenile myelomonocytic leukemia ORPHA:86834	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	CENPE
Lumbosacral spina bifida aperta ORPHA:268388	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Lumbosacral spina bifida cystica ORPHA:268758	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Muscle-eye-brain disease ORPHA:588	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Perrault syndrome ORPHA:2855	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Thoracolumbosacral spina bifida aperta ORPHA:268384	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Thoracolumbosacral spina bifida cystica ORPHA:268752	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Total spina bifida aperta ORPHA:268377	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Total spina bifida cystica ORPHA:268748	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Upper thoracic spina bifida aperta ORPHA:268740	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Upper thoracic spina bifida cystica ORPHA:268770	1/106	0.694654136661862	0.7068064785325423	0	0	0.8477914242620125	0.3088853468785006	GANAB
Catecholaminergic polymorphic ventricular tachycardia ORPHA:3286	1/107	0.6980615193295254	0.7072638369101406	0	0	0.839750704345599	0.30184674772854836	SORBS1
Frontotemporal dementia with motor neuron disease ORPHA:275872	1/107	0.6980615193295254	0.7072638369101406	0	0	0.839750704345599	0.30184674772854836	GANAB
Infantile nephronophthisis ORPHA:93591	1/107	0.6980615193295254	0.7072638369101406	0	0	0.839750704345599	0.30184674772854836	TET1
Juvenile nephronophthisis ORPHA:93592	1/107	0.6980615193295254	0.7072638369101406	0	0	0.839750704345599	0.30184674772854836	AMOTL2
Lennox-Gastaut syndrome ORPHA:2382	1/107	0.6980615193295254	0.7072638369101406	0	0	0.839750704345599	0.30184674772854836	CNTNAP2
MiT family translocation renal cell carcinoma ORPHA:319308	1/107	0.6980615193295254	0.7072638369101406	0	0	0.839750704345599	0.30184674772854836	GANAB
Myoclonic-astatic epilepsy ORPHA:1942	1/107	0.6980615193295254	0.7072638369101406	0	0	0.839750704345599	0.30184674772854836	CNTNAP1
Pituitary stalk interruption syndrome ORPHA:95496	1/107	0.6980615193295254	0.7072638369101406	0	0	0.839750704345599	0.30184674772854836	GLI2
Trichothiodystrophy ORPHA:33364	1/107	0.6980615193295254	0.7072638369101406	0	0	0.839750704345599	0.30184674772854836	TOMM22
Juvenile myoclonic epilepsy ORPHA:307	1/108	0.7014310479513476	0.7100092263364535	0	0	0.8318602782593987	0.2950048370121564	GPR137C
Progressive non-fluent aphasia ORPHA:100070	1/108	0.7014310479513476	0.7100092263364535	0	0	0.8318602782593987	0.2950048370121564	CTSD
Congenital stationary night blindness ORPHA:215	1/109	0.7047631410017597	0.7120423847116372	0	0	0.8241159711747947	0.2883528238931337	PLEKHD1
Isolated complex III deficiency ORPHA:1460	1/109	0.7047631410017597	0.7120423847116372	0	0	0.8241159711747947	0.2883528238931337	TOMM22
Situs ambiguus ORPHA:157769	1/109	0.7047631410017597	0.7120423847116372	0	0	0.8241159711747947	0.2883528238931337	CNTNAP2
Situs inversus totalis ORPHA:101063	1/109	0.7047631410017597	0.7120423847116372	0	0	0.8241159711747947	0.2883528238931337	IQCG
Common variable immunodeficiency ORPHA:1572	1/110	0.7080582125637306	0.7143653415082738	0	0	0.8165137614678899	0.2818842028481903	CORO1A
NON RARE IN EUROPE: Hypodontia ORPHA:2227	1/110	0.7080582125637306	0.7143653415082738	0	0	0.8165137614678899	0.2818842028481903	S100A14
Presynaptic congenital myasthenic syndromes ORPHA:98914	1/110	0.7080582125637306	0.7143653415082738	0	0	0.8165137614678899	0.2818842028481903	SCG2
Familial melanoma ORPHA:618	1/111	0.7113166722135179	0.7166448869866529	0	0	0.8090497737556561	0.2755927395910715	PPP1R14B
Meckel syndrome ORPHA:564	1/111	0.7113166722135179	0.7166448869866529	0	0	0.8090497737556561	0.2755927395910715	IQCG
Postsynaptic congenital myasthenic syndromes ORPHA:98913	1/111	0.7113166722135179	0.7166448869866529	0	0	0.8090497737556561	0.2755927395910715	RBM24
Walker-Warburg syndrome ORPHA:899	1/112	0.7145389248485955	0.7195544063051836	0	0	0.8017202723085076	0.2694724578730275	AMOTL2
Acute promyelocytic leukemia ORPHA:520	1/113	0.717725371062967	0.7224251630156712	0	0	0.7945216548157724	0.263517626431343	DOCK11
Behcet disease ORPHA:117	1/114	0.7208764069008574	0.7249187045096473	0	0	0.7874504464822007	0.25772274736995754	PSMB9
Non-syndromic male infertility due to sperm motility disorder ORPHA:276234	1/114	0.7208764069008574	0.7249187045096473	0	0	0.7874504464822007	0.25772274736995754	IQCG
NON RARE IN EUROPE: Autism ORPHA:106	1/115	0.7239924241175183	0.7277121423170946	0	0	0.780503294435183	0.2520825446436055	CNTNAP2
Normosmic congenital hypogonadotropic hypogonadism ORPHA:432	1/117	0.730120948200754	0.7335295427301692	0	0	0.7669683257918553	0.24124611039998684	ZCCHC12
Romano-Ward syndrome ORPHA:101016	1/118	0.7331342171496437	0.7362131755977757	0	0	0.7603743667092083	0.23604034364586615	SORBS1
Leber congenital amaurosis ORPHA:65	1/121	0.7419745367358114	0.7443958988603572	0	0	0.7412518853695325	0.22121947468090658	GPR137C
NON RARE IN EUROPE: Primary ovarian failure ORPHA:619	1/121	0.7419745367358114	0.7443958988603572	0	0	0.7412518853695325	0.22121947468090658	TET1
Familial atrial fibrillation ORPHA:334	1/122	0.7448560361137558	0.7469385786191998	0	0	0.735088440970794	0.2165308263072077	SORBS1
Williams syndrome ORPHA:904	1/124	0.7505232811725673	0.7522711230011014	0	0	0.7230622079976455	0.20750772396529382	GANAB
Genetic steroid-resistant nephrotic syndrome ORPHA:656	1/129	0.7641491074297374	0.765572103905398	0	0	0.6946408371040724	0.18685306566684406	CENPE
X-linked non-syndromic intellectual disability ORPHA:777	1/132	0.771966282542237	0.7730439460357812	0	0	0.6786294083105937	0.17563906678161298	ZCCHC12
Amyotrophic lateral sclerosis ORPHA:803	1/137	0.78442583699365	0.7851555354466673	0	0	0.6535134415757253	0.15867518534971542	GANAB
Autosomal recessive non-syndromic intellectual disability ORPHA:88616	1/140	0.7915737885959938	0.7919417912871124	0	0	0.639311175493994	0.1494275932967529	GANAB
Retinitis pigmentosa ORPHA:791	1/174	0.8578236036529228	0.8578236036529228	0	0	0.5127769204613816	0.07863782290741139	ARL2BP
